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Arsenic is a naturally-occurring toxicant that exists in bedrock and can be leached 
into ground water.  Humans can be exposed to arsenic via contaminated drinking water, 
fruit, rice or crops.  Epidemiological studies have shown that arsenic is a developmental 
toxicant, and in utero exposure reduces IQ scores, verbal learning ability, decreases long 
term memory, and increases the likelihood of dying from a neurological disorder. Arsenic 
can also reduce birth weight, weight gain, and muscle function after an in utero exposure. 
Although the mechanism behind these physiological changes is not known, in vitro 
studies have shown that arsenic can reduce muscle and neuronal cell differentiation. The 
purpose of this study was to investigate whether arsenic can disrupt signaling pathways 
or alter the expression of microRNAs that are important in stem cell differentiation.  We 
used P19 murine embryonic stem cells, which were exposed to 0, 0.25, or 0.5 µM 
arsenite for up to 9 days, to analyze the expression of developmental-related cell 
signaling pathways and microRNAs by microarray and quantitative PCR. While arsenic 
does not appear to impact FGF, Bmp nor Notch pathways, it does reduce transcript levels 
within the sonic hedgehog (Shh) signaling pathway, including the ligand Shh, the key 
transcription factor Gli2, and its target gene Ascl1, by 2-fold, 3-fold and 5-fold 
respectively. GLI2 protein expression was also reduced, leading to an inhibition of 
transcriptional activity. Additionally, exogenous SHH protein rescued the inhibitory 
effects of arsenic. Based on miRNA microarray data using of 1900 feature mouse 
miRNAs, Several miRNAs known to be important in development and/or stem cell 
differentiation, including miR-9, miR-92a, miR-199a, miR-291a and miR-709, were 
 iii 
altered by arsenic. Interestingly, a polycomb gene Sfmbt and its hosted miR-466-669 
cluster were induced from 1.5-to 3.5 fold by arsenic in a time-dependent manner. 
Moreover, knockdown of this cluster rescued the arsenic-mediated repression of Gli2 
expression and cell differentiation. Taken together, our results imply that arsenic inhibits 
P19 cell differentiation through repressing the Shh signaling pathway by decreasing Gli2 
expression and its activity, and the reduction of Gli2 is directly or indirectly regulated by 
miR-466-669 cluster. These results suggest two novel mechanisms by which arsenic 
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 Arsenic is a naturally occurring metalloid element that exists in bedrock, 
sediments and soils.  It can be found as a by-product of industrial activity including 
smelting, fossil fuel combustion, and pesticide production (Vahter, 2009).  By dissolving 
into the surrounding water, arsenic can exist in ground water and surface water (Amini et 
al., 2008).  Since arsenic can accumulate in soil, water, and airborne particles, it can be 
taken up by plants and marine organisms. Drinking water derived from groundwater has 
been reported as the most common source of human exposure to inorganic arsenic. 
Studies have shown that residents in China, Argentina, Taiwan, Bangladesh and USA are 
exposed to high level of arsenic via drinking water (ATSDR, 2007;  Blanes et al., 2011;  
Chen et al., 1994;  Nickson et al., 1998;  Ning et al., 2007).  
 For example, Blackfoot disease was originally found in areas of Taiwan where the 
concentration of arsenic in well water averages 671 ppb (Chen et. al. 1994).  In West 
Bengal, India and in Bangladesh, more than half of wells have water contaminated with 
arsenic, and estimates are that more than 9.5 million people could be drinking water 
above 10 ppb, while 53,000 people are exposed to arsenic at a level of 300 ppb (Rahman 
et al., 2015). Within the United States, arsenic contamination is found in southwest, 
upper Midwest, and in New England, with concentrations ranging from 10 to 200 ppb 
(Ryker, 2001).  Both the World Health Organization (WHO) and U.S. Environmental 
Protection Agency (USEPA) have set 10 parts per billion as the maximum allowable 
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standard for arsenic in drinking water (WHO, 2004).  Even with this limit, there are still 
more than one hundred million people worldwide at risk of elevated arsenic exposure. 
 There are many uses of arsenic in products such as pesticides, lead-acid storage 
batteries, anti-cancer drugs, and antimicrobial additives for animal and poultry feed 
(ATSDR, 2007).  Recently, an increasingly important source of exposure to inorganic 
arsenic is food, such as cereals, crops, and vegetables, which are cultured in arsenic-rich 
areas where farmers use groundwater for irrigation (Vahter, 2009) or in areas with 
historical arsenical pesticide use. Arsenic can accumulate in rice through the silicon 
transport system because arsenious acid, which exists in contaminated flooded rice 
paddies, is indistinguishable from silicic acid to the rice plant (Ma et al., 2008).  Thus, 
people consuming a diet rich in rice have urinary arsenic levels that are two-to-three fold 
higher than those consuming a wheat-based diet (He and Zheng, 2010). Moreover, 
another study shows that consumption of 0.56 cup per day of cooked  rice was 
comparable to drinking 1L/day of 10 µg As/L water, the current maximum contaminant 
limit in US (Gilbert-Diamond et al., 2011). Another study determined that the urinary 
arsenic concentration in children who reported consuming rice was 1.5 fold higher among 
those who did not consume rice, and the total urinary arsenic concentration increased 
14.2% with each 0.25 cup increase in cooked rice consumed (Davis et al., 2012).  These 
studies suggest that there are multiple exposure routes of arsenic, which raise concern 
about its effects on public health. 
 Arsenic has two biologically important oxidation states, arsenite, the trivalent 
form and arsenate, the pentavalent form. In the environment, inorganic arsenic can be 
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transformed into organic forms, such as methyl and dimethyl arsenic, by methanogenic 
bacteria (Ferguson and Gavis, 1972).  In mammals, inorganic arsenic can also be 
transformed into an organic form by metabolism. Briefly, arsenite can undergo oxidative 
methylation to methylarsonic acid [MMA(V)] by arsenic methyltranserases (As3MT). 
This pentavalent form can be reduced by glutathione to methylarsonous acid [MMA(III)], 
which is then transformed into dimethylated arsenic [DMA(III)] (Thompson, 1993). In 
general, the trivalent state is more toxic than the pentavalent state, and inorganic forms of 
arsenic are more toxic than methylated arsenic species. However, recent studies show that 
methylated trivalent arsenic metabolites have significant biological activity and may be 
as or more toxic than inorganic species (McCoy and Bain, 2015).  
 
Health Effects of Arsenic 
 Chronic exposure to arsenic has been reported to cause several adverse health 
effects. The typical dermal effects are the hyperkeratinization of skin which is considered 
a precursor lesion of nonmelanocytic skin cancers (ALAIN et al., 1993). A study using 
human keratinocytes (HaCaT) exposed to environmentally relevant concentrations of 
arsenite for 14 days found that p53 levels, a tumor suppressor gene which plays a critical 
role in DNA repair, were reduced by arsenic, suggesting a potential mechanism by which 
arsenic induced keratosis (Hamadeh et al., 1999). Patients exposed to arsenic are found to 
have multiple hyperkeratinized corns and spots of hypopigmentation (Rakhunde et al., 
2012). In West Bengal, India, residents consuming water containing at least 50 ppb 
arsenic had keratosis, and the incidence increases dose-dependently. Interestingly, men 
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have two to three times the prevalence than women with the same exposure level 
(Mazumder et al., 1998).  
 Another famous disease caused by arsenic is a peripheral vascular disease called 
Blackfoot disease (BFD), which was originally found in Taiwan (Tseng, 2002).  In 
Blackfoot disease, the blood vessels in the lower limbs are severely damaged, which 
reduces blood circulation around the limb tissue and thus causes tissue damage.  This 
damage can cause a progressive numbness or coldness of limbs, which may ultimately 
lead to gangrene. Between 1956 and 1960, the incidence of BFD was extremely high in 
the residents of the southwestern coast of Taiwan (Tseng, 2002).  Epidemiological studies 
found that residents had used deep artesian wells for drinking water since 1920s, where 
the arsenic concentration of the well water ranged from 700 to 930 ppb (Chen and Wu, 
1962).  Moreover, studies showed that there is a dose-dependent relationship between the 
prevalence of BFD and arsenic concentrations in well water, suggesting the link between 
arsenic exposure and BFD (Tseng, 2002). 
 Other than peripheral vascular disease, arsenic exposure is also associated with 
cardiovascular disease. Epidemiological studies in Taiwan demonstrated that long-term 
exposure to arsenic causes carotid atherosclerosis, ischemic heart disease and 
cerebrovascular disease (Navas-Acien et al., 2005).  In the United States, several studies 
showed a higher incidence of cardiovascular disease–related mortality, ischemic stroke 
admissions, hypertension, and coronary heart disease with increasing arsenic exposure 
(Engel and Smith, 1994;  Gong and O'Bryant, 2012;  Lisabeth et al., 2010). Moreover, a 
7-year study measuring the blood pressure of residents living in an arsenic contaminated 
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area suggests that long-term arsenic exposure accelerates age-related increases in blood 
pressure (Jiang et al., 2015).  
 Inorganic arsenic is considered a human carcinogen by the International Agency 
for Research on Cancer, as it causes skin, lung, bladder, kidney and liver cancer (Anders 
et al., 2004;  IARC, 2012). Convincing evidence from epidemiological studies show that 
arsenic can increase the risk of lung cancer in workers exposed to arsenic trioxide dust at 
copper smelters (Axelson et al., 1978;  Järup et al., 1989;  PERSHAGEN, 1985) and 
bladder cancers are also reported as an outcome in Argentina and Taiwan, where studies 
show a clear dose-response relationship between arsenic and bladder cancer (Chiou et al., 
1995;  Hopenhayn-Rich et al., 1996). 
 
Arsenic-Induced Development Toxicity 
  Several studies have shown that arsenic can cause developmental defects in 
humans. Developing organisms are usually more vulnerable to toxicants because of their 
rapid cell division and differentiation. Reports indicate that arsenic readily crosses the 
placenta, as similar arsenic levels are in the fetus and in the mother, with 9 μg/L arsenic 
in cord blood and 11μg/L in maternal blood, when consuming drinking water containing 
200ppb arsenic (Concha et al., 1998).  A cohort study in Bangladesh showed that women 
drinking tube-well water with more than 50μg/L arsenic during pregnancy significantly 
increased their risk of fetal loss and infant death (Rahman et al., 2007). Arsenic exposure 
also affects the development of the central nervous system, and can cause changes in 
hearing and increases in learning deficits (Bencko and Symon, 1977).  In Mexico, 
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children in an arsenic-contaminated area have lower verbal intelligence quotient (IQ) 
scores, decreasing from 96.7 to 91.2, along with a significant 11% reduction in long-term 
memory (Calderon et al., 2001). In 1955, more than 10,000 Japanese infants were 
exposed to arsenic through contaminated milk powder. The follow-up studies of the 
surviving infant victims 14 years later showed a 10-fold increase in IQ scores lower than 
85, and a 150-fold increase in those with a hearing disability, which suggests that the 
neurotoxicity is a concern of early lifestage exposure to inorganic arsenic (Dakeishi et al., 
2006).   
 Similar adverse effects of arsenic on development have been shown in animal 
models. Arsenic can easily pass through the placenta in rodents (Lindgren et al., 1984), 
and this reduced body weight and increased neurotoxicity in the offspring (Wang et al., 
2006).  For example, when pregnant rats were exposed to 0.3 and 3ppm arsenite via their 
drinking water, the pups showed decreased spontaneous behavior such as movement, 
shaking and tremors (Chattopadhyay et al., 2002).  Similarly, rats exposed to arsenite 
from GD15 up to 17 weeks via drinking water showed increased spontaneous locomotor 
activity and number of errors in a delayed alteration task compared to a control group 
(Rodriguez et al., 2002). These data suggest that arsenic exposure during gestation affects 
fetal development.  Arsenic can also affect embryonic development in fish.  Zebrafish 
embryos exposed to 10mM arsenite showed abnormal development including delayed 
hatching, shorter body length, and morphological changes including pericardial edema, 
dorsal curvature, flat head and RBC accumulation. Alterations in neural development and 
muscle development were also observed at 2 mM arsenic exposure (Li et al., 2009).  
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Arsenic Effects on Muscle and Neuron Development 
  Epidemiological studies have shown that arsenic (> 50 ppb) in drinking water 
causes infants to be born with low birth weight (average 57g less), and the incidences of 
stillbirth and neonatal mortality increase 2.5 and 1.8 fold, respectively (Hopenhayn et al., 
2003;  Milton et al., 2005;  Tofail et al., 2009;  von Ehrenstein et al., 2006). The 
incidence of arsenic contaminated milk powder in Japan mentioned above evidences the 
neuronal damage caused by arsenic (Dakeishi et al., 2006). These studies all suggest that 
chronic exposure of arsenic may cause adverse effects on both muscle and neuron 
development. This has been further shown using embryonic stem cells (ECS), in which 
arsenic caused a significant down-regulation of gene expression in all three germ layers 
(Flora and Mehta, 2009). Thus, embryonic stem cells may be an appropriate model for 
studying how arsenic impairs developmental.   It has been reported that exposure to low 
micromolar levels of sodium arsenite for five days reduced neurite production, 
outgrowth, and complexity in newly differentiating rat phaeochromocytoma-derived 
PC12 cells (Frankel et al., 2009). Wang et al. (2010) showed that, arsenic inhibited 
neurite outgrowth in Neuro-2a (N2a) neuroblastoma cells by inhibiting the LKB1 
(serine/threonine kinase 11)-AMPK (adenosine monophosphate-activated kinase) 
pathway, which controls cell growth in response to environmental nutrient changes 
(Wang et al., 2010). 
 With respect to muscle cell differentiation Yen et al. (2010) demonstrated that 
0.1–0.5 μM arsenic trioxide exposure decreased myogenic differentiation without 
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apparent effects on cell viability in C2C12 mouse myoblast cells, and also inhibited 
myotube formation and muscle regeneration after injury in mice by inhibiting Akt-
regulated signaling (Yen et al., 2010).  In their next study in 2012, higher concentrations 
(1-10 μM) of arsenic trioxide causes ROS-induced mitochondrial dysfunction by 
inactivating the Akt signaling pathway, which the authors hypothesized might be the 
reason for decreased skeletal muscle fiber formation (Yen et al., 2012).  In utero and 
postnatal exposure to arsenic resulted in increases of smooth muscle actin around 
airways, leading to alteration of pulmonary structure and function in mice (Lantz et al., 
2009).  In our laboratory, C2C12 mouse myoblast cells exposed to 20nM arsenite showed 
delayed myotube formation due to reductions in transcription factors such as myogenin 
and Mef2C. The mechanism believed to be responsible for this reduction is due to 
changes in promoter methylation (Steffens et al., 2011).  In P19 embryonic stem cells, 
arsenic exposure reduced both muscle and neuronal cell differentiation because of 
reduced neurogenic and myogenic transcription factor expression (Hong and Bain, 2012).  
In this study, β-catenin was down regulated, which suggested that arsenic may affect 
neurogenesis and myogenesis through the Wnt/β-catenin signaling pathway during 
embryogenesis (Hong and Bain, 2012). Although those studies indicated the adverse 
effect of arsenic on neurogenesis and myogenesis, the mechanism by which this occurs is 






  P19 cells are pluripotent murine embryonal carcinoma cells which were originally 
derived from a mouse teratocarcinoma (McBurney and Rogers, 1982). They can 
differentiate in culture into the 3 different germ layers and are useful for investigating 
developmental events such as signaling pathways and cell commitment determination 
(McBurney and Rogers, 1982).  In the presence of dimethyl sulfoxide (DMSO), 
aggregates of P19 cells can be induced into skeletal muscle and neuronal cells 
(McBurney and Rogers, 1982), while high concentration of retinoic acid can specifically 
induce cells to differentiate into neurons (Jones-Villeneuve et al., 1982).  
 Because of the established methods of cell differentiation, P19 cells have been 
used as an in vitro model for investigating several molecular mechanisms that play 
essential roles in mesoderm formation, neuronal formation, and axial elongation (Farah et 
al., 2000;  Marikawa et al., 2009).  Signaling pathways such as Wnt, Notch, BMP and 
Sonic Hedgehog are found involved in P19 cell differentiation (Gianakopoulos and 
Skerjanc, 2005;  Marikawa, Tamashiro, Fujita and Alarcón, 2009;  Nye et al., 1994;  van 
der Heyden and Defize, 2003). Therefore, P19 cells can be a valuable model for studying 
arsenic-induced developmental effects. 
 
Sonic Hedgehog (Shh) Signaling Pathway 
 During embryonic development, a limited number of signal transduction 
pathways are used to direct cells and control their differentiation. Sonic hedgehog (Shh) 
signaling is one of the evolutionarily conserved pathways and is needed for proper limb 
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development and neural progenitor cell survival (Anderson et al., 2012;  Litingtung and 
Chiang, 2000;  Mill et al., 2003). Studies have shown that Shh signaling can regulate the 
Wnt pathway to mediate neural circuit formation, indicating that Shh may play an 
important role in concert with the Wnt pathway (Wilson and Stoeckli, 2012).  As shown 
in Figure 1.1, the key proteins in the Shh pathway are zinc-finger transcription factors 
termed Gli. In the absence of Shh, the membrane receptor Patched (Ptch) inhibits 
Smoothened (Smo), which is held in intracellular vesicles. Gli2 protein is transferred to 
primary cilium by intraflagellar transport (IFT) and forms a complex with KIF7 and 
Suppressor of Fused (Sufu). The complex then binds to GSK3β and PKA to 
phosphorylate Gli2, leading to cleavage of Gli2 into a repressive form, thus inactivating 
the pathway.  When Shh is present, it binds to Patched on the membrane, resulting in the 
loss of inhibitory effect between Ptch and Smo. Smo is phosphorylated by GRK2 and 
then binds to KIF3A, which relocates Smo to the primary cilium. The increased Smo at 
the cilium leads to the dissociation of Sufu and Gli2, thus releasing full length of Gli2, 
allowing the active Gli2 to translocate into the nucleus and further induce cell 
differentiation (Anderson et al., 2012;  Ingham and McMahon, 2001;  Jiang and Hui, 
2008).   
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Figure 1.1. Schematic diagram of the Sonic Hedgehog signaling pathway.  
In the absence of Shh, the membrane receptor Ptch inhibits Smo’s movement to cilium. 
The complex of Gli2, Kif7 and Sufu is then phosphorylated by GSK3β and PKA, which 
leads to the cleavage of Gli2, thus inhibiting the signaling. Shh ligand reverses the 
inhibitory effect of Ptch on Smo. Smo is then phosphorylated and relocated to cilium, 
leading the dissociation of Gli2 complex. Full length of Gli2 then translocates to the 
nucleus and can transcribe downstream target genes.  
 
 Shh signaling is essential for myogenesis in zebrafish. When Shh signaling is lost 
in fish embryos, terminal myogenic differentiation of adaxial cells is delayed (Coutelle et 
al., 2001).  In mouse embryos, Gli2 has been shown to regulate Myf5 expression by 
binding specifically to the Myf5 enhancer (Gustafsson et al., 2002). Studies have shown 
that the lack of Shh signaling caused neural tube defects, which disrupted brain 
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development (Murdoch and Copp, 2010). In zebrafish, inhibition of Shh signaling using 
mutants reduces neural progenitor cell proliferation, thus affecting neurogenesis in the 
dorsal mesencephalon (Feijoo et al., 2011). Moreover, the mutation of Shh-related genes 
delays motor neuron differentiation in the mouse spinal cord, suggesting that Shh 
signaling is also important in neurogenesis (Oh et al., 2009).    
 
Arsenic’s Effects on Epigenetic Modifications 
 Epigenetics is the study of changing gene expression without altering DNA 
sequences, which can result in disrupting signaling pathway and cell morphology 
(Moore, 2015).  Epigenetic mechanisms include methylating DNA, modifying histone 
tails, and altering the expression of non-coding microRNAs (Moore, 2015). The 
developmental program of embryogenesis can be controlled by epigenetic mechanisms 
(Gan et al., 2007). During embryogenesis, mutation of the DNA methyltransferase gene 
results in embryonic lethality (Li et al., 1992).  Moreover, Azuara et al. examining the 
histone modification patterns in mouse ESCs showed that critical transcription factors for 
cell lineage determination, including Sox1, Nkx2-2, Msx-1, Irx3, and Pax3, were 
associated with activating (H3 Lys-9 acetylation and H3 Lys-4 methylation) and 
repressive (H3 Lys-27 methylation) histone modifications within their promoter loci 
(Azuara et al., 2006). Therefore, epigenetic alterations play an important role in 
understanding development defects.  
 The epigenetic effects of arsenic have been studied in several model systems. 
Arsenic can modify the amount of DNA methylation.  For example, Mass and Wang 
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found that arsenic exposure resulted in promoter hypermethylation of the tumor 
suppressor gene p53, resulting in arsenic-induced carcinogenesis (Mass and Wang, 
1997).  Zhao et al. transformed rat liver cells into malignant tumors by exposing them to 
0.5 μM inorganic arsenic for 18 weeks. Interestingly, the transformed cells showed global 
hypomethylation compared to normal cells, indicating the potential epigenetic 
mechanism of carcinogenesis induced by arsenic (Zhao et al., 1997).   A previous study 
in our lab using C2C12 mouse myoblast cells showed that arsenic can alter the 
methylation patterns on the transcription factor myogenin, thereby delaying their 
differentiation into myotubes (Steffens et al., 2011).  
 How arsenic alters DNA methylation is likely related to the way cells metabolize 
arsenic. Inside a cell, inorganic arsenic can be methylated by arsenite methyltransferase 
(As3MT) using S-adenosyl methionine (SAM) as the methyl donor. The depletion of 
SAM inhibits DNA methyltransferase (DNMT) activity by feedback inhibition, resulting 
in changes to DNA methylation patterns (Caudill et al., 2001).  
 Beyond DNA methylation, arsenic exposure can also modify histone methylation, 
acetylation, and phosphorylation patterns (Ren et al., 2011). Cronican et al. showed that 
prenatal exposure to arsenic caused a genome-wide alteration of histone H3K9 
acetylation patterns (Cronican et al., 2013). Another study exposing human lung cancer 
cells to inorganic arsenic resulted in increased H3K9 dimethylation and decreased 
H3K27 trimethylation, both of which represent gene silencing marks (Zhou et al., 2008).  
Previous studies in our lab using C2C12 mouse myoblast cells have shown that arsenic 
exposure can increase H3K9 di- and tri-methylation by 4-5-fold and reduce H3K9 
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acetylation by 2-fold on the MyoD promoter, all of which are silencing marks.  MyoD is 
needed to convert myoblasts into myotubes, so the histone modifications provide a 
potential mechanism for how arsenic can inhibit cell differentiation (Steffens et al., 
2011).   
 
MicroRNAs 
 The third epigenetic modifiers are microRNAs (miRNAs), which are small, single 
stranded, non-coding RNAs that regulate gene expression. Primary microRNAs are 
transcribed by RNA polymerase II as stem-loop structures. Following cleavage by  
RNAse III family protein, Drosha, in the nucleus, the primary form becomes a small 
hairpin that is termed as pre-miRNA (Lee et al., 2002).  Pre-miRNAs are then exported to 
the cytoplasm and cleaved by Dicer, another RNAse III family protein, thus releasing 
mature miRNAs (~22 nucleotides) (Hutvagner et al., 2001;  Ketting et al., 2001). 
MicroRNAs in animals bind imperfectly to the 3’ untranslated region (UTR) of mRNA, 
leading to targeted mRNA translational repression (Yang et al., 2005).  
 Because of its ability to regulate gene expression, microRNAs play an important 
role in development.  In mice, deletion of the gene Dicer-1, which cleaves pre-miRNA to 
produce mature miRNAs, results in the embryonic lethality (Bernstein et al., 2003).  
Moreover, Kanellopoulou et al. showed that the lack of Dicer-1 in mouse embryonic stem 
cells significantly reduces cell differentiation and centromeric silencing (Kanellopoulou 
et al., 2005).  Expressions of several miRNAs are related to cell differentiation.  For 
instance, miR-1 and miR-133 are highly expressed in muscle lineages in several species, 
 15 
indicating the evolutionary conservation of the tissue-specific expression (Kwon et al., 
2005;  Simon et al., 2008;  Zhao et al., 2005).  Both of these miRNAs are regulated by 
the transcription factor MyoD or MEF2 in skeletal muscle and cardiac muscle, 
respectively (Liu et al., 2007;  Zhao et al., 2005). miR-1 and miR-133 promote 
mesoderm formation and are potent repressors of nonmuscle genes during cell lineage 
commitment (Ivey et al., 2008).  miR-124 and miR-9 are both critical for neurogenesis, 
because they increase several transcription factors, including Foxg1, Sox9 and Pax6 
(Akerblom et al., 2012;  Cheng et al., 2009;  Clark et al., 2010;  Otaegi et al., 2011;  
Shibata et al., 2011).  
 MicroRNAs can be located in in the genome separately or in the intron of a host 
gene (Rodriguez et al., 2004).  Several miRNA families are clustered together within the 
genome and are transcribed as a polycistronic transcript. For instance, the miR-17-92 
cluster is found within the intron region of C12orf25 and it contains six miRNAs, miR-
17-5p, miR-18a, miR-19a, miR-20a, miR-19b-1, and miR-92a-1, within 1kb on 
chromosome 13 (Ota et al., 2004;  Tanzer and Stadler, 2004).  The miR-290 cluster is 
identified as a 2.2-kb region on chromosome 7, and its primary transcript generates 14 
mature miRNAs which can promote pluripotency maintenance by regulating cell cycle 
phase distribution in mouse embryonic stem cells (Judson et al., 2009;  Lichner et al., 
2011). The miR-466 cluster is located in the intron 10 of the mouse Sfmbt2 gene on 
chromosome 2 and contains more than 40 miRNAs (Zheng et al., 2011).  It is reported to 
be involved apoptosis and osmoregulation (Druz et al., 2011;  Luo et al., 2014), but there 
are likely to be other unknown functions and targets.  
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  Compare to other epigenetic modifications, the effects of arsenic on miRNA 
regulation is relatively unexplored. A study using arsenic trioxide (ATO) as an anticancer 
drug found that arsenic exposure increased miR-29a expression, thereby inhibiting cell 
growth and inducing apoptosis (Meng et al., 2011). Moreover, Ghaffari et al. identified 
several miRNAs that are altered by ATO in acute promyelocytic leukemia cells, with the 
up-regulated miRNAs involved in tumor suppressor functions and the down-regulated 
miRNAs related to angiogenesis, invasion and metastasis (Ghaffari et al., 2012).   Cui et 
al. showed that arsenite exposure induced angiogenesis by decreasing miR-9 and miR-
181b expression (Cui et al., 2012).  Arsenic also induced miR-190 expression in human 
bronchial epithelial cells, thus enhancing cell proliferation and carcinogenic 
transformation by target tumor suppressor gene PHLPP (Beezhold et al., 2011).  
Moreover, low level of arsenic exposure (2.5 µM) in human bronchial epithelial cells 
caused malignant transformation by reducing the level of miR-200 family members. 
Overexpressing miRNA-200b in this arsenite-transformed cell line reversed the 
transformed phenotype (Wang et al., 2011). With increasing evidence showing the 
importance of miRNAs in development and arsenic-induced miRNAs alteration, how 
arsenic alters miRNA expression and whether this change causes development defects 






Dissertation Goals and Objectives 
  The goal of this dissertation is to determine the mechanism by which arsenic 
reduces P19 embryonic stem cell differentiation. Previous studies have shown that 0.5 
μM arsenite inhibits P19 cell differentiation by reducing transcription factors, such as 
MyoD and myogenin, and NeuroD and neurogenin, needed for the formation of skeletal 
myotubes and sensory neurons, respectively.   Therefore, I plan on investigating how 
arsenic causes transcription factor repression.   I hypothesize that arsenic will alter the 
Shh signaling pathway, and/or alter microRNA expression in the stem cells, thereby 
leading to reduced neurogenesis and myogenesis in P19 cells. My goal will be 
accomplished by two objectives: 
 
 Objective 1: Determine if arsenic inhibits Sonic Hedgehog signaling during 
cell differentiation of mouse P19 embryonic stem cells. We will expose P19 stem cells 
to 0.25 μM or 0.5 μM sodium arsenite and examine expression and localization changes 
in Shh pathway genes (Shh, Gli1, Gli2, Patch1, and Sufu) during the cells’ differentiation 
from pluripotent cells into myotubes and sensory neurons. Cells will also be treated with 
Shh protein to see if they can recover from the inhibitory effects of arsenic. 
 
 Objective 2: Determine if arsenic reduces cell differentiation by altering 
miRNA expression.  P19 stem cells are exposed to arsenic during their differentiation 
into skeletal myotubes and sensory neurons.  Global microRNA expression will be 
determined by microarrays, and validated with qPCR. miRNA inhibition will be 
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conducted to determine if specific miRNA knock-down can recover the arsenic-mediated 
reduced differentiation.  
   By better understanding the mechanisms of action of arsenic, we can develop the 
potential treatments for those who are exposed to high level of arsenic around the world, 
especially for infant development. Moreover, we can also apply arsenic as a cancer 
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Arsenic is a toxicant found in ground water around the world, and human 
exposure mainly comes from drinking water or from crops grown in areas containing 
arsenic in soils or water.  Epidemiological studies have shown that arsenic exposure 
during development decreased intellectual function, reduced birth weight, and altered 
locomotor activity, while in vitro studies have shown that arsenite decreased muscle and 
neuronal cell differentiation.  The sonic hedgehog (Shh) signaling pathway plays an 
important role during the differentiation of both neurons and skeletal muscle. The 
purpose of this study was to investigate whether arsenic can disrupt Shh signaling in P19 
mouse embryonic stem cells, leading to changes muscle and neuronal cell differentiation.  
P19 embryonic stem cells were exposed to 0, 0.25, or 0.5 μM of sodium arsenite for up to 
9 days during cell differentiation. We found that arsenite exposure significantly reduced 
transcript levels of genes in the Shh pathway in both a time and dose-dependent manner.  
This included the Shh ligand, which was decreased 2- to 3-fold, the Gli2 transcription 
factor, which was decreased 2- to 3-fold, and its downstream target gene Ascl1, which 
was decreased 5-fold. GLI2 protein levels and transcriptional activity were also reduced. 
However, arsenic did not alter GLI2 primary cilium accumulation or nuclear 
translocation. Moreover, additional extracellular SHH rescued the inhibitory effects of 
arsenic on cellular differentiation due to an increase in GLI binding activity. Taken 
together, we conclude that arsenic exposure affected Shh signaling, ultimately decreasing 
the expression of the Gli2 transcription factor. These results suggest a mechanism by 
which arsenic disrupts cell differentiation.   
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Arsenic is a naturally occurring metalloid that exists in bedrock, sediments and 
soils.  Drinking water derived from groundwater has been reported as the most common 
source of human exposure to inorganic arsenic. According to the U.S. Environmental 
Protection Agency and the World Health Organization, the drinking water standard for 
arsenic is 0.01mg/L (10 ppb). Even with this limit, residents in several counties, 
including Bangladesh, China, India, Pakistan, Taiwan, Hungary, Argentina, and Mexico, 
who are still at risk of elevated arsenic exposure due to high concentrations of arsenic in 
ground water (Naujokas et al., 2013). An increasingly important source of exposure to 
inorganic arsenic is food, such as cereals, crops, and vegetables, which are cultured in 
arsenic-rich areas where farmers use groundwater for irrigation or in areas with historic 
arsenic-based pesticide usage. Both epidemiological and animal studies showed that 
arsenic exposure causes adverse developmental effects such as fetal loss, infant death, 
low intelligence quotient scores, reduced birth weight, and reduced weight gain 
(Calderon et al., 2001; Rodriguez et al., 2002; Wang et al., 2006a; Huyck et al., 2007; 
Rahman et al., 2007; Li et al., 2009; Bloom et al., 2014), suggesting that arsenic 
exposure impacts development.      
In addition to the reductions in body weight and changes in neuronal function, 
arsenic exposure has been shown to decrease muscle and neuron development. For 
example, exposure to micromolar levels of arsenite reduced neurite production, 
outgrowth, and complexity in differentiating rat PC12 cells (Frankel et al., 2009), while 
in Neuro-2a neuroblastoma cells, arsenic inhibited neurite outgrowth by inhibiting the 
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LKB1 AMPK  pathway (Wang et al., 2010). Arsenic also induced neural tube defects in 
mouse embryos (Wlodarczyk et al., 1996). Exposure to arsenic trioxide exposure in 0.1-
0.5 μM range decreased myogenic differentiation in C2C12 mouse myoblast cells and 
during muscle regeneration after injury in mice by inhibiting Akt-regulated signaling (18). 
Similarly, C2C12 mouse myoblast cells to be exposed to 20 nM sodium arsenite showed 
delayed myotube formation due to reductions in transcription factors such as myogenin 
and myocyte enhancer factor 2C (Mef2C) (Steffens et al., 2011).  These results suggest 
that arsenic inhibits skeletal muscle and neuronal differentiation without affecting 
proliferation.   
Sonic hedgehog (Shh) signaling is an evolutionarily conserved pathway that is 
needed for somite formation, patterning of embryonic structures, and neural progenitor 
cell survival (Litingtung and Chiang, 2000; Mill et al., 2003; Anderson et al., 2012).  
Studies have shown that Shh signaling is essential for myogenesis in zebrafish since 
without Shh signaling, adaxial cells are delayed in terminal differentiation (Coutelle et 
al., 2001). In mouse cells, hedgehog signaling regulates both cardiac and skeletal 
myogenesis, as the transcription factor of hedgehog signaling, Gli2, has been shown to 
regulate and activate Mef2c and MyoD expression, which are transcription factors needed 
for myogenic differentiation of progenitor cells (Voronova et al., 2012; Voronova et al., 
2013). Shh signaling is also critical for neuronal development. Studies have shown that 
lack of Shh signaling disrupts dorso-ventral pattering within the neural tube in mice 
(Chiang et al., 1996; Murdoch and Copp, 2010). In zebrafish, inhibition of Shh signaling 
by using mutants that lack essential components of the Shh pathway, like Smoothen (Smo) 
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and Gli, reduces neural progenitor cell proliferation in the dorsal mesencephalon (Feijoo 
et al., 2011). Moreover, mice with mutations in Shh and Gli show a delay in motor 
neuron differentiation in spinal cord, suggesting that Shh signaling is also important in 
neurogenesis (Oh et al., 2009).    
The key proteins of Shh pathway are zinc-finger transcription factors family 
termed Gli. Gli2 is the primary transcription factor of Shh signaling pathway. It has two 
different activities based on post-translational modification, in which the full length 
protein acts as activator and the truncation of its C-terminus acts as repressor. Gli1 acts as 
a minor activator and is involved in cellular growth and cell cycle progression (Sun et al., 
2014), and Gli3 is a transcriptional repressor, but its expression is very low (Hui and 
Angers, 2011).  In the absence of SHH, the membrane receptor Patched (PTCH) inhibits 
the activity of Smoothened (SMO), a 7-pass transmembrane protein. GLI2 protein is 
transferred to the primary cilium and forms a complex with KIF7 and Suppressor of 
Fused (SUFU).  The complex then binds to GSK3β and PKA to phosphorylate GLI2, 
leading to the cleavage of GLI2 into a repressive form and inactivating the pathway (Kim 
et al., 2009).  When SHH is present, it binds to PTCH on the membrane, resulting in the 
loss of inhibitory effect between PTCH and SMO. SMO is then phosphorylated by GRK2 
and translocated to primary cilium, which cause the accumulation of SMO in primary 
cilium. Accumulation of SMO in primary cilium leads to the dissociation of SUFU and 
GLI2, releasing full length of GLI2, and therefore allowing the active GLI2 to translocate 
into the nucleus and induce cell differentiation (Ingham and McMahon, 2001; Jiang and 
Hui, 2008). 
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Arsenic trioxide is used as a chemotherapeutic agent, and it has been recently 
shown to inhibit the Hedgehog pathway in cancer cells by inhibiting GLI proteins. For 
example, arsenic trioxide decreased Hh-induced ciliary accumulation of GLI2 and 
increased its rate of degradation (Kim et al., 2010). Another study found that in the 
Ewing sarcoma cell line, arsenic trioxide inhibited hedgehog signaling by inhibiting GLI1 
protein transactivation (Beauchamp et al., 2011). Other studies have shown that arsenic 
trioxide exposure in several cancer cell lines decreased the transcription of GLI1, GLI2 
and PTCH1, leading to the inhibition of cell growth (Nakamura et al., 2013; Yang et al., 
2013). Taken together, arsenic trioxide inhibits Shh signaling in cancer cells at the level 
of GLI transcription factors. Thus, we were interested in whether arsenic can also alter 
Shh signaling in embryonic stem cells, thereby reducing cellular differentiation.  
  In our previous study, arsenic exposure inhibited both skeletal muscle and neuronal cell 
differentiation in P19 embryonic stem cells by reducing the expression of MyoD and 
NeuroD1, transcription factors needed for myogenesis and neurogenesis respectively 
(Hong and Bain, 2012).  However, the mechanism by which arsenic inhibits cell fate 
determination is not fully understood. In the present study, we examined whether sodium 
arsenite affects sonic hedgehog signaling during cell differentiation. Our findings indicate 
that sodium arsenite specifically decreased Gli2 expression and transcriptional activity, 
thereby reducing the levels of several of its downstream targets. When additional 
recombinant SHH protein was added, SHH rescued arsenic’s inhibitory effects on cell 
differentiation. Taken together, our results indicate that arsenic inhibit cell differentiation 
into myotubes and neurons by inhibiting sonic hedgehog signaling.  
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Material and methods 
P19 cell culture and differentiation 
The mouse embryonal carcinoma P19 cell line (ATCC, Manassas, VA) was 
maintained in -MEM supplemented with 7.5% bovine calf serum (Hyclone, Logan, 
UT), 2.5% fetal bovine serum (Mediatech, Manassas, VA), 1% L-glutamine, and 1% 
penicillin/streptomycin (designated as growth medium) at 37C in a humidified incubator 
containing 5% CO2.  To induce differentiation, P19 cells were aggregated by the hanging 
drop method with some modifications (Wang and Yang, 2008).  Briefly, P19 cells were 
trypsinized and suspended in growth medium containing 1% DMSO with 0, 0.25, or 0.5 
μM sodium arsenite at a cell density of 500 cells/ 20l or drop.  Hanging drops were 
incubated for 2 days (day 2) to let cells undergo aggregation. After 2 days, each 
individual drop was transferred to a 96-well ultralow attachment plate containing fresh 
differentiation medium with or without sodium arsenite. After 3 days of culture (day 5), 
the embryoid bodies were transferred to a 0.1% gelatin coated 48-well plate containing 
fresh differentiation medium with or without sodium arsenite. Medium was then renewed 
every 48 hours until cells were harvested.  
 
Developing stable Gli reporter gene transfectants 
P19 cells were transfected with a Gli-luciferase lentiviral reporter (pCignal Lenti-
TRE-Reporter) following supplier’s instructions (SABiosciences, CA) to develop a stably 
transfected cell line. Briefly, P19 cells were seeded in 24 well cell culture plate (2×10
3 
cells per well) for 1 day to avoid over confluency. Cells were then transfected with 
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Cignal lentiviral particles for 20 hours and recovered in normal growth medium 
afterward. To isolate stable transfectants, 2µg/mL puromycin was added into each well 
for a total of 14 days, while passaging the cells every two days.   To assess arsenic’s 
effects on hedgehog signaling, the stable cells were plated at 5000 cells cells/well in a 12 
-well plate and exposed to 0, 0.25, or 0.5 µM sodium arsenite for 48 hours (n= 3).  
Additionally, the stably transfected cells were exposed to 0 or 0.5M arsenite while being 
differentiated into mature embryoid bodies via the hanging drop method as above (n= 3). 




After 2 or 5 days of exposure, ninety six aggregating embryoid bodies (1 plate) 
were collected as one replicate (n=3 per treatment group per day). Total RNA were 
extracted using TRI reagent (Sigma-Aldrich, St. Louis, MO) and reverse transcribed 
using M-MLV Reverse Transcriptase (Promega) according to the manufacturer’s 
protocol. Real-time qPCR was conducted using RT
2
 SYBR green master mix (Qiagen, 
Valencia, CA) and appropriate primers as shown in Table 2.1. A standard curve was 




ng of cDNA) to quantify expression 
levels and assess reaction efficiency.  Samples were run in triplicate and gene expression 
data was analyzed and normalized with the Gapdh housekeeper using the comparative 




Cells were treated with 0, 0.25, or 0.5 μM arsenite and  harvested at days 2 and 
days 5 as described above (n=3 per group per day).  Collected cells were placed in RIPA 
lysis buffer (Thermo Scientific, Waltham, MA) with protease and phosphatase inhibitors 
(Thermo Scientific).  Cell culture medium was also collected from day 5 embryoid bodies 
to collect exosomes.  Briefly, medium was passed through a 0.2m filter and incubated 
with ExoQuick-TC isolation reagent overnight at 4
o
C (Systems Biosciences, Mountain 
View, CA).  Exosomes were isolated by centrifugation per manufactuer’s instructions 
and lysed in RIPA buffer with protease and phosphtase inhibitors.   Protein 
concentrations were quantified using Bio-Rad’s DC protein assay kit.  Immunoblots were 
performed according to standard methods.  Dilutions for primary antibodies were as 
follows: anti-GLI2 (1:200, Santa Cruz, #SC-271786), anti-GSK3β (1:1000, Cell 
Signaling, #9315), anti-phospho-GSK3β (Ser9) (1:1000, Cell Signaling, #9323), anti-
SHH (1:1000, Cell Signaling, #2207), and GAPDH (1:1000, IMGENEX, #IMG-5019A). 
Secondary antibodies and dilutions were as follows: goat anti-mouse-HRP (1:2000, Santa 
Cruz, #SC-2005) and goat anti-rabbit-HRP (1:2000, #SC-2004). The amount of protein 
was detected by chemiluminescence (Luminol, Santa Cruz) using BioRad’s Chemidoc 
imaging system. Average densitometry values were determined using BioRad’s Quantity 






Differentiating P19 cells were exposed to 0, 0.25, and 0.5 μM sodium arsenite as 
described above. After 2 days and 5 days of cells aggregation, 96 embryoid bodies were 
harvested as one replicate (n=3 per day per group).  Embryoid bodies were fixed in 10% 
neutral buffered formalin, dehydrated, and embedded in paraffin. Sections (5 μm) were 
placed on slides, deparaffinized and rehydrated in graded ethanol. Slides were blocked 
and incubated with specific primary antibodies for one hour (GLI2 (C-10) 1:400, Santa 
Cruz, #SC-271786) and incubated with secondary antibody conjugated to Alexa Flour 
488 (Invitrogen, Carlsbad, CA). DAPI (Invitrogen) was used to stain nuclei. 
Immunofluorescence was measured on a Ti Eclipse Inverted Microscope (Nikon, 
Melville, NY).  Overall fluorescence intensity was quantified and normalized with 
nuclear intensity using Image J to obtain the average GLI2 expression per cell 
(Barbachano et al., 2010). Relative quantification units were calculated after normalizing 
with the intensity values to the control groups.   For the later stages of differentiating 
cells, embryoid bodies exposed to arsenic as described above were transferred to 0.1% 
gelatin coated glass chambers (n = 4 per treatment per group). Cells were cultured for 7 
more days with the renewal of medium every two days. Cells were fixed with 4% of PFA 
at room temperature for 10 minutes, permeablilized and blocked with 0.2% Triton-X-100 
and 1% BSA respectively. Cells were stained with the appropriate primary antibody for 1 
hour (TUJ1 1:200, Millipore #MAB1637; NANOG 1:100, GeneTex #GTX100863; GLI2 
1:100, Abcam #AB26056; Acetylated-Tubulin 1:5000, Sigma #T7451) and incubated 
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with Alexa Flour 488, 568 conjugated secondary antibody (Invitrogen, 1:2000) and 
DAPI. Fluorescence was measured via Nikon Ti Eclipse Inverted Microscope.    
 
SHH rescue 
SHH-N terminal peptide (1 or 2.5 µg/mL) (R&D System, Minneapolis, MN) was 
dissolved in growth medium and P19 cell differentiation was conducted via the standard 
method described above, with or without 0.5 μM sodium arsenite. After five days, 
aggregated embryoid bodies were transferred onto a 48 well 1% gelatin coated plate and 
cultured for additional 4 days. Eight individual differentiated embryoid bodies per treated 
group were imaged on day 9 (n=8 per concentration). The length and area of 
differentiating and proliferating cells was quantified using ImageJ. 
Stable GLI-luciferase reporter cells were plated at 5000 cells cells/well in a 12 -well plate 
and exposed to 0 or 0.5 µM sodium arsenite with or without 1µg/mL SHH-N terminal 
peptide for 24 hours (n= 3).  Luciferase activity was measured using One-Glu luciferase 
assay kit.  
 
Statistical analysis 
  Results are expressed as mean ± S.E.M.  Data were analyzed by ANOVA 
followed by Tukey’s HSD Test or t-test, as appropriate.  Statistical significance was 





Arsenic decreases Sonic hedgehog pathway related gene expression  
To determine what signaling pathways were involved in arsenic’s ability to 
reduce stem cell differentiation into skeletal myotubes and sensory neurons, we examined 
mRNA expression of key proteins in pathways known to be involved in cellular 
differentiation.  P19 cells treated with 0, 0.25μM and 0.5μM of sodium arsenite were 
harvested at days 4 and 6 of differentiation. Key transcripts examined included Bmp4, 
Fgf4, Fgf8, Hes1 expression for the Notch pathway, and Shh and Gli2 for the Shh 
pathway.  During the process of embryoid body formation, Shh, Gli2, and Bmp4 
expression increased by 2.5-, 6-, and 2.5-fold, respectively (Figures 2.1A-C), Hes1 and 
Fgf4 expression decreased by 3- and 8-fold respectively (Figures 2.1D and E), and Fgf8 
expression did not change (Figure 2.1F).  Arsenic exposure reduced transcript levels of 
both Shh expression (2-fold) and Gli2 expression (1.5-fold), respectively, during 
embryoid body formation (Figure 2.1A and B), but did not change the levels of any of the 
other transcription factors.  To further examine Shh pathway related gene expression, P19 
cells exposed to 0 or 0.5μM sodium arsenite were harvested at 2, 5, 7 and 9 days of 
differentiation. Transcript levels of Shh, the transcription factor Gli2, and three 
downstream genes: Gli1, Ptch1, and Ascl1 were determined. Over the time of 
differentiation, both Shh and Gli2 were significantly increased by 5 days of 
differentiation and expressed at high levels until day 9, supporting the role of Shh 
signaling in P19 cell differentiation. Arsenic exposure significantly reduced the 
expression of Shh and Gli2 transcripts by 2.5-fold and 3-fold, respectively, on day 5. 
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These reductions were maintained at days 7 and 9, indicating that the inhibitory effects of 
arsenic on cell differentiation are related to Shh signaling (Figure 2.2A and B). Three 
Gli2 downstream target genes were also examined. There was no difference in Gli1 and 
Ptch1 expression level when exposed to arsenic (Figure 2.2C and D).  Gli1 expression 
was down regulated during early embryoid body formation and remained reduced 
throughout the differentiation period (Figure 2.2C).  Ptch1 levels remained relatively 
constant from days 0-9 (Figure 2.2D), suggesting that it has only a minor role in cell 
differentiation. Ascl1 is another Gli2 downstream gene, and studies have shown that an 
increase in its expression can promote neuronal differentiation (Voronova et al., 2011). 
During P19 cell differentiation, Ascl1 expression was induced dramatically in controls 
cells, while arsenic exposure decreased Ascl1 expression by 2.5, 7, and 4-fold on days 5, 
7, and 9, respectively (Figure 2.2E). Taken together, the data suggests that arsenic 
decreases Shh pathway gene expression, thus inhibiting cell differentiation.  
 
Arsenic exposure does not alter the levels of SHH expression nor GLI2 accumulation in 
the primary cilum.  
Since the genes whose expression was reduced after arsenic exposure were the 
Shh signal itself and the Gli2 transcription factor, we first examined SHH protein levels.  
Day 5 embryoid bodies exposed to 0 or 0.5 µM arsenic were collected along with the 
culture medium to assess secreted SHH levels contained in exosomal vesicles.  In day 5 
embryoid bodies, we were able to visualize both precursor and processed SHH, but 
arsenic exposure did not alter either one of their levels (Figure 2.3A). The secreted 
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precursor and processed SHH was at a much higher molecular weight, likely in the 
cholesterol bound form (Porter et al., 1996). However, its expression in the exosomes 
also remained constant between control and arsenic exposed cells (Figure 2.3B). Shh 
signaling activation causes ciliary accumulation of GLI2, resulting in GLI2 nuclear 
translocation, which further activates Shh signaling downstream genes (Chen et al., 2009; 
Kim et al., 2009). We investigated if arsenic inhibited GLI2 accumulation in primary 
cilium by differentiating P19 cells for 9 days in 0 or 0.5 µM arsenic, and co-staining them 
with the primary cilium marker acetylated-tubulin and GLI2. There is no difference 
between control and arsenic exposed cells (Figure S2.1).    
 
Arsenic decreases GLI2 protein levels  
GLI protein families are the key transcription factors in Shh signaling. Therefore, 
we determined whether GLI2 protein levels were altered after exposure to arsenic. GLI2 
protein exists in a full length active (~160 kDa) form and in a repressor form (~78 kDa) 
after C-terminal truncation (Pan et al., 2006a). Western blot confirms that the active full-
length form of GLI2 is decreased when exposed to arsenic in day 5 embryoid bodies 
(Figure 2.3C and D), although the antibody used cannot detect the truncated repressor 
form.  We also examined GLI2 levels by immunohistochemistry.  In day 2 embryoid 
bodies, GLI2 protein is expressed, but most of it remains outside the nucleus.  There is 
also no difference in expression between control and arsenic exposed embryoid bodies 
(Figure 2.4).  By day 5, the majority of GLI2 is translocated to the nuclei in both groups.  
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However, overall GLI2 expression is significantly reduced by 50% in the arsenic-exposed 
cells (Figure 2.4).  
 
Arsenic inhibits GLI activity 
Since arsenic reduced the levels of GLI2 protein, we wanted to determine if the 
activity of GLI2 was also inhibited after arsenic exposure.  P19 cells were used to 
generate a stable transfectant containing the GLI protein binding element adjacent to a 
luciferase reporter gene. Cells were exposed to 0.25 and 0.5 µM of sodium arsenite for 48 
hours prior to assessing activity. The results show that GLI activity was significantly 
decreased by 40% when exposed to 0.5 µM arsenite (Figure 2.5A). We further 
determined if GLI activity was inhibited during cell differentiation by forming embryoid 
bodies from the transfected cells.  GLI activity was also reduced by 35% in the arsenic-
exposed embryoid bodies, indicating that arsenic decreases Shh signaling activity when 
P19 cells are undergoing differentiation (Figure 2.5B).  
 
Arsenic does not disrupt GSK3β phosphorylation 
In order to generate truncated GLI2 protein, GSK3β phosphorylates GLI2, leading 
it to be partially processed by proteasomes (Aza-Blanc et al., 1997). GSK3β kinase 
activity can be inhibited by phosphorylation of its serine 9 site (Godemann et al., 1999). 
Therefore, we examined if arsenic disrupted GSK3β kinase activity by determining the 
level of total and phosphorylated GSK3β.  However, there were no significant changes 
between control and arsenic treated day 5 embryoid bodies (Figure 2.6).   
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Induction of the Shh pathway rescues arsenic’s inhibitory effects on cell differentiation 
To determine if stimulating the Shh pathway activity rescues the arsenic-mediated 
reduction in cell differentiation, 1 µg/mL of mouse recombinant SHH N-terminal domain 
protein was added into growth medium during cell differentiation and morphological 
changes were observed in the cells after 9 days of exposure. As shown in figure 2.7A, 
cells around the original embryoid bodies within the dashed line were defined as 
undifferentiated cells and were confirmed with NANOG staining (data not shown). The 
control group had less than 50% of undifferentiated cells and more spindle-shaped 
mesenchymal cells and myocytes that are migrating out from the embryoid bodies 
(Figure 2.7A). When cells were exposed to SHH only, neither migration distance nor 
percentage of differentiating cells changed, but there were more myocytes around the 
embryoid bodies. The cells exposed only to 0.5 µM arsenic had less differentiating cells 
and shorter migration distance. When cells were co-treated with 0.5M arsenic and SHH, 
there were more differentiated cells outside of the embryoid bodies and fewer 
undifferentiated cells compared to the arsenic-only group, indicating that SHH protein 
rescues the arsenic-induced inhibition on cell differentiation (Figure 2.7B).  
  In order to further confirm the rescue, P19 cells were co-treated with 2.5 µg/mL of 
recombinant SHH N-terminal domain protein and 0.5 µM of sodium arsenite during cell 
differentiation. After 12 days of differentiation, the number of neuronal cells was 
determined by stained with neuron specific marker TUJ1. The arsenic-treated cells have 
less neurons, but when cells are co-treated with SHH, many more neuronal cells are seen, 
suggesting that SHH attenuates the inhibitory effects caused by arsenic (Figure 2.7C).   
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To examine the mechanism by which SHH rescues the arsenic-induced inhibition of 
cellular differentiation, stable GLI protein binding element-luciferase cells were exposed 
to 0.5 µM arsenite with or without 1g/mL SHH for 24 hours. GLI activity was 
significantly decreased by 20% when exposed to 0.5 µM arsenite (Figure 2.8).  However, 
when the cells were co-incubated with arsenic and SHH, relative GLI activity was 
equivalent to the controls (Figure 2.8).  This data suggests that the rescue of cellular 
differentiation by SHH is due to increases in GLI activity.  
 
Discussion: 
In the present study, the mechanisms by which arsenic disrupts during cell 
differentiation in P19 embryonic stem cells were examined, focusing on cell signaling 
pathways.  Arsenic specifically reduces the expression of genes in the Shh signaling 
pathway, such as Shh, Gli2 and Ascl1. GLI2 protein levels and transcriptional activity 
were also decreased by arsenic during cell differentiation. The inhibition of activity is not 
caused by changes in SHH protein levels, GLI2 nuclear translocation, GLI2 primary 
cilium accumulation, or GLI2 degradation.   However, the arsenic-mediated reduction in 
cell differentiation can be recovered by treating the cells with additional recombinant 
SHH protein due to an increase in GLI activity.  These results suggest that Shh signaling 
is a target of arsenic during cellular fate determination. 
It has been previously shown that arsenic can inhibit cellular differentiation in 
P19 embryonic stem cells (Hong and Bain, 2012) as well as in human neuronal stem cells 
and rat cardiac myoblasts (Steffens et al., 2011; Ivanov and Hei, 2013; Sumi et al., 2013). 
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However, except for the P19 cells, these other cells are progenitor cells which have 
already been restricted to certain cell fates. After screening several growth signaling 
pathways including the Notch, Bmp, Fgf, and Shh pathways, arsenic exposure decreased 
the expression of Shh and its transcription factor Gli2 in P19 cells, but did not affect key 
proteins in the other pathways. 
Hes1 is a bHLH transcriptional factor which is directly regulated by Notch 
signaling and has been shown to negatively regulate cell differentiation (Kageyama et al., 
2005).  Its expression was reduced during cell differentiation study, but was not altered 
by arsenic exposure.  Fgf4 and Fgf8 signals are important growth factors during 
embryogenesis, with Fgf4 expression increasing early in embryogenesis and Fgf8 
expression increasing slightly later (Wang et al., 2006b; Lanner and Rossant, 2010).  
Bmp4 belongs to the TGFβ superfamily, which is both critical to induce embryonic cell 
differentiation and is also upregulated during cardiomyocyte differentiation (Monzen et 
al., 1999; Bragdon et al., 2011).  Our qPCR data of those genes shows patterns consistent 
with those studies above.   Although the transcripts of these decreased and increased, 
respectively, during differentiation, their expression was again not impacted by arsenic.  
  The down-regulation of Shh signaling pathway was also examined over a longer time 
period.  Gli1 and Gli2 are both transcription factors in Shh signaling, but their expression 
patterns are different based upon whether the cells are proliferating or whether they are 
differentiating.  Gli1 expression is down regulated after forming embryoid bodies, 
indicating that is has a minor role in cell differentiation.   This is similar to several studies 
in mice, in which Gli2 appears to be the primary transcriptional activator, while Gli1 is 
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not required for embryonic development (Mo et al., 1997; Ding et al., 1998; Bai et al., 
2002).   Indeed, in P19 cells, Gli2 is upregulated rather than Gli1 after 5 days of cell 
differentiation (Voronova et al., 2013), which is similar to what is seen in our study.  
Moreover, reports have shown that Gli2 regulates Pax3 and MyoD expression during 
skeletal and cardiac myogenesis (Petropoulos et al., 2004; Voronova et al., 2013).  In our 
previous study, Pax3 and MyoD were down regulated when exposed to arsenic.  
Therefore, it is not surprising that arsenic only inhibits Gli2 expression.  This is also 
similar to reductions in Gli2 transcripts in several cancer cell lines, leading to the 
inhibition of cellular growth (Nakamura et al., 2013; Yang et al., 2013).  Ascl1 is a bHLH 
transcription factor that has been reported to convert embryonic fibroblasts to functional 
neurons and to induce neurogenesis in P19 cells (Farah et al., 2000; Vierbuchen et al., 
2010), and is a target of Gli2 during Gli2-induced neurogenesis (Voronova et al., 2011).  
Ascl1 was also inhibited by arsenic in the same pattern as Gli2.  Taken together, these 
results indicate that the arsenic-mediated inhibitory effect on cell differentiation is due to 
the inhibition of the Shh signaling pathway.    
There are several potential protein targets of arsenic within the Shh pathway 
between the SHH ligand itself and the Gli2 transcription factor.  In vertebrates, SHH 
protein is a morphogen that controls central nervous system and limb development in a 
tightly regulated dose- and time-dependent manner (Yang et al., 1997; Briscoe and 
Ericson, 2001; Ahn and Joyner, 2004; Harfe et al., 2004). The Shh gene has cis-
regulatory elements that lie up to 1000kB upstream of its transcriptional start site, and it 
appears that each tissue has a means for intrinsic or self-regulation (Dessaud et al., 2007; 
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Bastida et al., 2009; Benazet et al., 2009; Anderson and Hill, 2014).   SHH protein is 
processed by cleavage, and the final product modified with choleseterol and palmitate 
moieties, as well as with heparin sulfate (Beachy et al., 2010).  The modifications allow 
SHH protein to form multimeric complexes, to be anchored to the cell membrane, or to 
vesicle membranes, and the modifications also correlate with its signaling potency (Chen 
et al., 2004; Grover et al., 2011).  Our results show that SHH protein expression is very 
robust in both the P19 cells themselves as well as in secreted, exosomal vesicles, 
although arsenic exposure does not alter SHH protein expression.  This may be a reason 
why our SHH rescue required so much protein compared to other studies.  In typical cell 
culture experiments, the concentration of additional, exogenous SHH required to induce 
neuronal and muscle differentiation from ES cells varies from 0.1 to 0.5μg/mL (Dutton et 
al., 1999; Elia et al., 2007; Salero and Hatten, 2007).  We exposed P19 cells to 
concentrations ranging from 0.2 to 2.5μg/mL, but the SHH-mediated rescue only 
occurred at concentrations of at least 1 μg/mL.   
PTCH1 is a transmembrane protein that is the receptor of SHH ligand and acts as 
a repressor in the absence of SHH signaling (Agren et al., 2004). However, Ptch1 
expression can also be regulated in a Shh-independent manner (Agren et al., 2004).  Our 
data indicates that Ptch1 expression is not significantly changed by arsenic and its 
expression does not change during the cell differentiation period.  Along with PTCH1, 
other plasma membrane proteins can also bind to SHH.  For example, Hedgehog 
interacting protein (HHIP) appears to compete directly with PTCH for SHH binding, 
resulting in an inhibition of SHH signaling activity (Chuang and McMahon, 1999). We 
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do not know whether HHIP levels are increased, but this may be a reason why SHH 
levels are not altered, but Shh signaling is reduced. 
Shh signaling results in active GLI2 formation when GLI2 dissociates from the 
Suppressor of fused (SUFU) in the primary cilium due to the accumulation of 
Smoothened (SMO) (Murdoch and Copp, 2010).  In the absence of SHH, SMO is 
prevented from entering the primary cilium, leading to GLI2 protein processing and 
degradation by the proteasome (Kim et al., 2009).  Investigators have shown that in 
cancer cells, arsenic trioxide decreased the Hh-induced ciliary accumulation of GLI2 
(Beauchamp et al., 2011).  However, we co-stained differentiating day 9 cells exposed to 
arsenic with acetylated-tubulin, a primary cilium marker, and GLI2, and found no effect 
on the ciliary accumulation of GLI2 when exposed to arsenic (Figure S2.1).        
In the primary cilium, GLI2 can be processed to a repressive form if its C-
terminus is truncated (Sasaki et al., 1999). The antibody used in the GLI2 
immunoblotting and immunohistochemistry assays recognizes amino acids 841-1140 of 
GLI2, which should identify only active GLI2.  Whether it can identify the repressive 
form is unknown, but this is unlikely because the processing determinant domain (PDD) 
of GLI2 is between amino acids 648-915 (Pan and Wang, 2007) and, although processing 
of GLI2 into the truncated repressor form occurs in vivo, the repressor form is typically 
undetectable in cell culture conditions (Pan et al., 2006b). We can determine reductions 
in active GLI2 protein levels (Figure 2.3), but cannot visualize any cleaved repressive 
proteins on our blots. Phosphorylation of GLI2 by GSK3β is a critical step for GLI2 to be 
truncated into repressive form or cleaved by the proteosome.  Our data shows no 
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inhibition of GSK3β kinase activity when exposed to arsenic, indicating that arsenic did 
not affect the GSK-mediated phosphorylation.  However, more evidence is needed to 
determine whether arsenic targets other kinases, such as protein kinase A and casein 
kinase (Hui and Angers, 2011), thus increasing the phosphorylation and proteosomal 
degradation of GLI2 protein.   
After active GLI2 is released from the primary cilium, it acts as a transcription 
factor.  Our immunohistochemistry data indicates that GLI2 does not accumulate in the 
nucleus until day 5 of embryoid body formation, which indicates that the Shh signaling 
pathway starts between day 2 and 5.  This supports our qPCR results that Gli2 and other 
downstream transcription factors have significantly higher expression after day 5.  
However, the relative nuclear translocation between control and arsenic exposed 
embryoid bodies were not changed.  This indicates that nuclear translocation was not 
altered; only the total GLI2 level.  But, this reduction in total GLI2 protein does correlate 
with the reductions in GLI2 activity seen in the reporter gene assays.  In addition, 
exogenous SHH can rescue the loss of differentiation in P19 cells after arsenic exposure 
by increasing GLI activity.   
Beyond the increase in GLI activity, there are several other mechanisms of 
regulating Shh pathway signaling.  For example, we have previously published that β-
catenin, a key transcription factor of Wnt signaling, is down regulated in P19 cells that 
are exposed to arsenic (Hong and Bain, 2012).  It is reported that in P19 cells, short 
hairpin RNAs targeting β-catenin transfectants also decreased Gli2 expression during cell 
differentiation (Wong et al., 2013).  Indeed, it is well-known that crosstalk exists between 
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the Wnt and Shh pathways (Winkler et al., 2014). Recent studies suggested that 
epigenetic regulation including DNA methylation, histone modification and microRNA 
(miRNAs) expression can be mediated by arsenic exposure (Ren et al., 2011).  Indeed, 
arsenic is well-known to cause oxidative stress in cells, which can alter DNA and histone 
modifications (reviewed in Chervona and Costa, 2012). Gli2 expression can also be 
decreased by oxidative stress in both animal models and in cultured astrocytes (Xia et al., 
2012; Ji et al., 2012).  Studies have shown that microRNAs participate in development 
and cell differentiation through regulating growth related gene expression (Kim, 2005; 
Hou et al., 2012; Kawahara et al., 2012). Moreover, a recent study shows that miR-326 
represses Shh signaling activity by directly targeting Gli2 expression in embryonic lung 
epithelium cells (Jiang et al., 2014). Taken together, arsenic-caused inhibitory effects on 
Shh signaling might also be due to changes in epigenetic regulation.  
Results of the present study demonstrate that arsenic exposure reduces GLI2 
transcript and protein expression and GLI transcriptional activity, thereby reducing P19 
cell differentiation into neuronal and muscle cells.   Although SHH levels are not 
changed, additional SHH ligand rescues the inhibitory effects caused by arsenic.  We 
excluded other possible targets in Shh signaling such as GLI2 primary cilium 
accumulation, GLI2 nuclear translocation, and extracellular SHH expression. Our studies 
provide the insight into the mechanism by which arsenic alters during cell differentiation. 
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Figure 2.1. Arsenic decreased hedgehog pathway gene expression during cell 
differentiation. 
P19 cells treated with 0, 0.25μM and 0.5μM of sodium arsenite were harvested at days 4 
and 6 of embryoid body formation (n=3 per day and concentration). The expression of 
key genes in differentiation signaling pathways were examined. Values were normalized 
with Gapdh as the housekeeping gene and average fold changes were compared to 
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undifferentiated P19 cells (day 0). Statistical differences were determined by Student’s t-






















































































































































































Figure 2.2.  P19 cells exposed to arsenic during differentiation repress hedgehog 
pathway related gene expression in a time-dependent manner.  
RNA was extracted from differentiating P19 cells, with or without 0.5 μM sodium 
arsenite exposure, on days 0, 2, 5, 7, and 9.  Transcript levels of sonic hedgehog signaling 
pathway genes (Gli1, Gli2, Ptch1, Shh, Ascl1) were determined by qPCR analysis (n=3 
per group per day). Values were normalized to Gapdh and all expression fold changes 
were compared to day 0 control cells. Statistical differences were determined by 
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Figure 2.3.  Arsenic reduces GLI2 protein levels, but not SHH levels. 
P19 cells were induced to differentiate for 5 days while being exposed to 0, 0.25, or 
0.5M arsenic.  Protein was extracted from both the cells and secreted exosomes.  SHH 
levels in the cells were assessed by immunoblotting (n=3 per treatment group) and were 
normalized using GAPDH (A).  SHH levels in the exosomes were examined by 
immunoblotting (n=2 per group) (B).  Full length GLI2 levels were also examined by 
immunoblotting, with results normalized to GAPDH (n=3 per group) (C).  GLI2 protein 
levels were analyzed by densitometry, were averaged, and are expressed as the fold-
change from control cells + standard deviation (D).  Statistical differences were 
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Figure 2.4. Arsenic decreases GLI2 protein levels in day 5 embryoid bodies. 
After exposure to 0 or 0.5 µM arsenic, day 2 and day 5 embryoid bodies were embedded 
in paraffin and GLI2 expression examined by immunofluorescence (A). Overall day 5 
fluorescence intensity was quantified as integrated intensity per cell (n=5 slides per 
treatment group) (B).  Results were normalized to the control group and statistical 
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Figure 2.5. Arsenic decreases GLI reporter activity in P19 cells.  
P19 cells were stably transfected with a GLI binding element-luciferase plasmid.  Stable 
transfectants were then exposed to 0, 0.25, and 0.5 µM sodium arsenite for 48 hours and 
luciferase activity was assessed by luminometry (A). The stable strain was also 
differentiated into embryoid bodies for 5 days while being exposed to 0 or 0.5 µM 
arsenite, and luciferase activity measured (B).  Luminesce values were averaged, 
normalized to the controls, and are expressed as a relative reporter activity value + SEM 
(n=3 per concentration).  Statistical differences were determined by ANOVA analysis 
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Figure 2.6. Arsenic exposure does not affect GSK3β phosphorylation. 
Days 5 embryoid bodies were exposed to 0, 0.25 and 0.5 µM of arsenic and were 
harvested for protein extraction. GLI2, GSK3β and phospho-GSK3β (Ser9) expression 
































Figure 2.7.  Additional Shh rescues arsenic’s inhibitory effects on cell 
differentiation. 
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P19 cells were aggregated via hanging drops with or without 1g/mL recombinant SHH 
protein and 0.5 µM of sodium arsenite. Embryoid bodies were transferred to 0.1% gelatin 
coated plates after 5 days and were differentiated for an additional 4 days to observe 
morphological changes.  The embryoid body is pictured in the top right corner, while the 
dashed line delineates the boundary between differentiated and undifferentiated cells 
(confirmed by NANOG expression). The longest distance of migration is shown as a 
green bar from a representative image (A). The percentage of undifferentiated cells 
compared to total migration area was calculated for each group, and statistical differences 
were determined by ANOVA followed by Tukey’s (*; p<0.05).  Error bars represent + 
S.D. from ten replicates (n=10) (B).   P19 cells were differentiated for 12 days with or 
without 2.5 µg/mL recombinant SHH protein and 0.5 µM sodium arsenite.  Cells were 















Figure 2.8.  Shh rescues GLI activity after arsenic exposure. 
GLI-luciferase transfected P19 cells were exposed to 0 or 0.5M arsenite with or without 
1g/mL recombinant Shh protein for 24 hours.  Luciferase activity was assessed by 
luminometry.  Luminesce values were averaged, normalized to the controls, and are 
expressed as a relative reporter activity value + SEM (n=3 per concentration).  Statistical 
differences were determined by ANOVA analysis followed by Tukey’s HSD test (*; 


























































Figure S2.1. Arsenic does not affect ciliary accumulation of GLI2 during cell 
differentiation. 
P19 cells were aggregated through handing drop method in the presence or absence of 0.5 
µM sodium arsenite for 9 days. Cells were fixed and stained to visualize GLI2, 
acetylated-tubulin, and DAPI (A). The levels of ciliary GLI2 were quantified from 
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Humans can be exposed to arsenic via drinking water, rice, and fruits grown in 
areas with naturally-occurring arsenic or in areas with historical pesticide use. Chronic 
arsenic exposure can result in adverse development effects including decreased 
intellectual function, reduced birth weight, and altered locomotor activity. Previous in 
vitro studies have shown that arsenic inhibits stem cell differentiation.  MicroRNAs 
(miRNAs or miRs) are small non-coding RNAs involved in multiple cellular processes 
including embryonic development and cell differentiation. The purpose of this study was 
to examine whether altered miRNA expression was a mechanism by which arsenic 
inhibited cellular differentiation.  P19 embryonic stem cells were exposed to 0 or 0.5 μM 
sodium arsenite for 9 days during cell differentiation, and miRNA microarrays were 
analyzed for changes.  We found that several developmental-related miRNAs, such as 
miR-9 and miR-199 were decreased by 1.9- and 1.6-fold respectively, while miR-92a, 
miR-291a, and miR-709 were increased by 3-, 3.7- and 1.6-fold, respectively. The 
members of the miR-466-669 cluster and its host gene, Sfmbt2, were significantly 
induced by arsenic from 1.5- to 4-fold in a time-dependent manner.  This induction 
appears to be specific to stem cells, because changes in miR-466-669 members were not 
found in more differentiated cell lines, including neuroblast and myoblast cells. When 
consensus sequences targeting the whole miR-466-669 cluster were co-exposed to P19 
cells, this rescued the inhibitory effects of arsenic on cell differentiation. Taken together, 
we conclude that arsenic induced the miR-466-669 cluster specifically in embryonic stem 
cells, which acts to inhibit cellular differentiation. 
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Arsenic is a ubiquitous element that is widely distributed in the bedrock, 
sediments and soils, and can leach into ground water and surface water (Amini et al., 
2008). Humans can be easily exposed to arsenic via drinking water from contaminated 
wells (ATSDR, 2007).  Studies have shown that residents are exposed to high level of 
arsenic in their drinking water in countries such as China, Argentina, Taiwan, Bangladesh 
and the USA (ATSDR, 2007;  Blanes et al., 2011;  Chen et al., 1994;  Nickson et al., 
1998;  Ning et al., 2007).  Both the World Health Organization (WHO) and U.S. 
Environmental Protection Agency (USEPA) have set 10 ppb arsenic as the drinking water 
standard (WHO, 2004).  Other than drinking water, humans can also be exposed to 
arsenic by consuming crops, such as rice, that are grown in soil with former arsenic 
pesticide use (Zavala et al., 2008).   
Arsenic can cross the placental barrier such that arsenic concentrations in cord 
blood are almost as high as in maternal blood (Concha et al., 1998).  Therefore, children 
can be affected by arsenic during pregnancy. Epidemiological studies have shown that 
arsenic can increase the rates of spontaneous abortion and stillbirth with increasing 
maternal arsenic exposure (Quansah et al., 2015;  Rahman et al., 2010).  Maternal arsenic 
exposure in pregnancy has also been found to reduce newborn birth weight by an average 
of 57g (Hopenhayn et al., 2003;  Huyck et al., 2007;  Rahman et al., 2009).  Moreover, 
data from more than 20 epidemiological studies of children 7 months old to 15 years old 
exposed to arsenic levels > 10 ppb show that arsenic reduces verbal IQ, spatial memory, 
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and long-term memory, indicating that arsenic can also affect intellectual function during 
development (Tolins et al., 2014).  
Several in vitro studies have shown that arsenic impacts cell differentiation.  For 
example, exposing C2C12 myoblasts to 0.1 μM arsenic trioxide or 20nM sodium arsenite 
inhibits myotube formation (Yen et al., 2010; Steffens et al., 2011).  Arsenite reduced 
muscle cell differentiation by down-regulating the expression of transcription factors 
involved in myotube formation, such as MyoD and myogenin (Steffens et al., 2011). 
Arsenic also disrupts neuronal differentiationand neurite outgrowth in both PC12 and 
Neuro-2a neuroblastoma cells (Frankel et al., 2009; Wang et al., 2010). Our previous 
work demonstrates that arsenic inhibits the differentiation of mouse P19 embryonic stem 
cells into myotubes and sensory neurons by repressing the expression and nuclear 
translocation of β-catenin, and reducing the expression and activity of Gli2, a key 
transcription factor in the sonic hedgehog signaling pathway (Hong and Bain, 2012; Liu 
and Bain, 2014).  However, the mechanism by which arsenic reduces transcription factor 
expression is not well understood. 
   One potential mechanism for altering transcript and protein expression is through 
the use of microRNAs (miRNAs).  miRNAs are small, single stranded, non-coding RNAs 
that regulate gene expression by binding imperfectly to the 3’ untranslated region (UTR) 
of mRNA, leading to targeted mRNA translational repression (Yang et al., 2005).  
MicroRNAs can be located in introns or outside of genes (Rodriguez et al., 2004).  If 
several miRNAs are clustered together, they can be transcribed as a polycistronic 
transcript.  For instance, the miR-17-92 cluster is found within an intron of C12orf25 and 
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it contains six miRNAs within about 1kb, including miR-17-5p, miR-18a, miR-19a, miR-
20a, miR-19b-1, and miR-92a-1 (Ota et al., 2004;  Tanzer and Stadler, 2004). The miR-
290 cluster is a 2.2-kb region on chromosome 7, and the primary transcript generates 14 
mature miRNAs which play an important role in embryonic stem cells (Judson et al., 
2009).  The miR-466 cluster is located in intron 10 of the mouse Sfmbt2 gene and 
contains 65 miRNA genes (Lehnert et al., 2011). There is little information reported on 
this cluster, other than it is involved in apoptosis and osmoregulation (Druz et al., 2011;  
Luo et al., 2014).  
   Because of their ability to regulate gene expression, microRNAs play an 
important role in development.  In mice, deletion of the Dicer-1 gene, which cleaves pre-
miRNA to produce mature miRNAs, can result in embryonic lethality (Bernstein et al., 
2003). Moreover, mouse embryonic stem cells which lack Dicer-1 have significant 
defects in cell differentiation (Kanellopoulou et al., 2005). Several miRNAs impact stem 
cell differentiation into skeletal muscle and neurons. For instance, miR-1 and miR-133 
are regulated by the transcription factors MyoD and MEF2 to target Hand2 and serum 
response factor (SRF), respectively (Liu et al., 2007;  Zhao et al., 2005).  miR-1 and 
miR-133 promote mesoderm formation and are potent repressors of nonmuscle gene 
during cell lineage commitment (Ivey et al., 2008). miR-124 and miR-9 are both critical 
for neurogenesis and are both highly expressed in the brain (Cheng et al., 2009;  Shibata 
et al., 2011).  Several neurogenic transcription factors, including Foxg1, Sox9, and Pax6, 
have been identified as targets of miR-9 and miR-124 (Akerblom et al., 2012;  Clark et 
al., 2010;  Otaegi et al., 2011;  Shibata et al., 2011). 
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  Compared to other epigenetic modification, the effects of arsenic on miRNA 
regulation are relatively unexplored.  Arsenic trioxide (ATO) exposure to liver cancer 
cells increased miR-29a expression, which inhibited cell growth and induced apoptosis 
(Meng et al., 2011).  ATO also alters several miRNAs in acute promyelocytic leukemia 
cells; with the up-regulated miRNAs related to tumor suppressor functions and the down-
regulated miRNAs related to angiogenesis, invasion, and metastasis (Ghaffari et al., 
2012).  Beyond arsenic trioxide in cancer cells, only a few other studies indicate that 
inorganic arsenic can alter miRNAs levels.  For example, arsenite exposure can induce 
angiogenesis by decreasing miR-9 and miR-181b expression in a human umbilical vein 
cell line (Cui et al., 2012). Arsenic also induced miR-190 expression in human bronchial 
epithelial cells, thus enhancing cell proliferation and carcinogenic transformation by 
targeting the tumor suppressor gene PHLPP (Beezhold et al., 2011).  Similarly, arsenite 
exposure in human bronchial epithelial cells caused malignant transformation by 
reducing the level of miR-200 family members, (Wang et al., 2011). Since increasing 
evidence indicates that miRNAs are important in development, cellular differentiation, 
and that arsenic exposure can alter miRNAs levels, we hypothesized that arsenic could 
alter miRNA expression during cell differentiation, leading to the disruption of 
differentiation process.   
  In the present study, we exposed mouse P19 embryonic stem cells to arsenite 
during cell differentiation and determined that several miRNAs were differentially 
expressed. Interestingly, the miRNA-466-669 cluster was significantly increased along 
with its host gene Sfmbt2 following arsenic exposure. This induction appears to be an 
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early cell lineage response, as the levels of miR-466/467/669 did not change in myoblasts 
and neuroblasts.  In addition, when the miR-466-669 cluster was inhibited by anti-miRs, 
this rescued the inhibitory effects on differentiation mediated by arsenic. These results 
indicate that miR-466-669 cluster is highly expressed when exposed to arsenic, which 
leads to the inhibition of stem cell differentiation.  
 
Material and Methods 
Cell culture and differentiation 
   Mouse embryonal carcinoma P19 cells (ATCC, Manassas, VA) were cultured in 
MEM Alpha medium (Hyclone, Logan, UT) with 7.5% bovine calf serum (Hyclone), 
2.5% fetal bovine serum (Sigma-Aldrich, St. Louis, MO), 1% L-glutamine, and 1% 
penicillin/streptomycin (designated as growth medium). Cells were maintained in a 
humidified incubator containing 5% CO2 at 37℃. Embryoid bodies were formed and the 
cells were differentiated for up to 9 days using the hanging drop method as described 
previously (Liu and Bain, 2014).    
   Neuro2a neuroblastoma cells were cultured in DMEM medium (Hyclone, Logan, 
UT) with 10% fetal bovine serum (Sigma-Aldrich, St. Louis, MO), 1% L-glutamine, and 
1% penicillin/streptomycin (designated as growth medium). To induce  differentiation, 
growth medium was replaced with DMEM medium containing 2% fetal bovine serum, 
1% L-glutamine, 1 % penicillin/streptomycin and 20 μM all-trans retinoid acid 
(designated as differentiation medium) (Frankel et al., 2009).  Cells were exposed to 0, 1, 
or 2.5µM arsenite during this process.  The mouse myoblast C2C12 cell line (ATCC, 
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Manassas, VA) were cultured in DMEM supplemented with 10% fetal bovine serum, 1% 
L-glutamine, and 1% penicillin/streptomycin (growth media). To differentiate the cells, 
the medium was replaced with DMEM supplemented with 2% horse serum, 1% L-
glutamine, and 1% penicillin/streptomycin (differentiation media) (Steffens et al., 2011).  
Cells were exposed to 0 or 20nM arsenite during this process. 
 
miRNA microarrays 
   P19 cells were exposed to 0 or 0.5μM arsenic as sodium arsenite and induced to 
differentiate for 9 days (n=3).  Cells were harvested, and total RNA was extracted with 
TRIzol (Life Technologies, Grand Island, NY) with extra ethanol cleaning step to 
improve the quality of RNA used. Three replicates samples were pooled together equally 
and hybridized onto two LC Sciences murine miRNA microarray chips (Houston, TX) 
per exposure group.  The array included probes for all available mature mouse miRNAs 
(miRBase database, Release 21, July 2014).  Fluorescence intensity was corrected by 
background subtraction and normalized with the statistical mean of all detectable 
transcripts. Intensity values for the control and 0.5 μM arsenic-exposed cells were 
averaged, and statistical differences assessed using a Student’s t-test.  
 
miRNA reverse transcription and miRNA specific qPCR 
  Total RNA (1μg) was used to reverse transcribe miRNA (QuantiMir RT kit, 
System Biosciences, Mountain View, CA).  Quantitative real-time PCR was performed 
with RT
2
 SYBR green master mix (Qiagen, Valencia, CA) using adapter-specific reverse 
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primers.  Gene specific miRNA forward primers are listed in Table 3.1. A standard curve 
was generated by serial dilution to determine PCR efficiency. Samples were run in 
triplicate and the expression data was analyzed and normalized with U6 as a housekeeper 
using the comparative threshold (Ct) method (Livak and Schmittgen, 2001).   
 
Real-time quantitative PCR 
  P19 cells were exposed to 0 or 0.5μM arsenic, induced to differentiate, and 
collected at day 0, 2, 5, and 9 (n=3 per treatment group per day). Total RNA were 
extracted using TRIzol, and 2μg RNA were reverse transcribed using M-MLV reverse 
transcriptase (Promega).  Real-time qPCR was conducted using RT
2
 SYBR green 





ng cDNA) to quantify expression levels and assess 
reaction efficiency. Samples were run in triplicate and gene expression data was analyzed 
and normalized with the Gapdh housekeeper using the comparative threshold (Ct) 
method.  
 
miRNA inhibition assay 
Four consensus sequences which target the miR-466-669 cluster were selected for 
anti-miRNA generation (Figure 3.4).  The oligonucleotides (Integrated DNA 
Technologies, Coralville, Iowa) were modified by employing 2'-O-methyl RNA 
nucleotides linkages positioned at both ends to block exonuclease attack (Lennox et al., 
2013).  P19 cells were transfected with 100 nM miRNA inhibitor using Lipofectamine 
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2000 (Invitrogen), and allowed to differentiate as above for 5 days with or without 0.5μM 
sodium arsenite.  At day 5, the embryoid bodies were transferred into gelatin coated plate 
and cultured for 4 more days without additional anti-miR.   
 
Chromatin immunoprecipitation(ChIP) assays 
   P19 cells were induced by aggregation with or without 0.5 µM sodium arsenite as 
described above and were harvested at differentiation day 5 (n=3). Chromatin was 
extracted and sonicated using a Vibra Cell probe (Sonic and Materials Inc, Danbury, CT) 
using 25% power output for 450 seconds and run on a gel to ensure appropriate 
fragmentation. Both chromatin extractions and immunoprecipitations were performed 
according to standard protocols (Abcam Inc., Cambridge, MA).  The antibodies used for 
ChIP assays were anti-H3K9 Ac (ab4441, Abcam) and H3K9 Me2 (ab1220, Abcam).  
Normal mouse IgG (sc-2025, Santa Cruz) was used as a negative control. Quantification 
of precipitated DNA was performed by qPCR using SYBR green with miR-466-669 
cluster and Sfmbt2 promoter-specific primers (Table 3.1). Percentage of input method 
was used to normalize threshold (Ct) values with input samples [100*2^(Ct (Adjusted 
input) - Ct (IP))]. 
Statistical analysis 
   Results are expressed as mean ± S.E.M.  Data were analyzed by ANOVA 
followed by Tukey’s or Student’s t-test, as appropriate.  Statistical significance was 




Arsenic alters the microRNA expression profile during P19 cell differentiation 
     A murine microRNA microarray containing 1900 mature transcripts (miRBase 
Release 21.0) was used to determine which miRNAs were altered by arsenic after 9 days 
of P19 cell differentiation.  A total of 59 miRNAs were significantly changed, with 27 
miRNAs decreased and 32 miRNAs increased, in the arsenic-exposed cells (Figure 3.1).  
Several of these miRNAs are known to impact development and stem cell differentiation 
(Table 3.2).  miR-92a is highly expressed in stem cells and its expression decreases when 
cells undergo differentiation. miR-291a belongs to the miR-290~295 cluster, which 
promotes pluripotency and prevents cells from differentiating. miR-709 inhibits 
adipocyte differentiation by targeting the GSK3βWnt signaling pathway.  Arsenic 
exposure to P19 cells increased these transcripts, which is consistent with the repression 
of differentiation (Figure 3.1).  These changes were validated by miRNA qPCR, in which 
miR-92a, miR-291a, and miR-709 were all significantly induced in arsenic treated cells 
by 3-, 3.5-, and 1.6-fold, respectively (Figure 3.2 A,B,C). In contrast, miR-9 induces 
neuronal cell differentiation and miR-199a increases chondrogenesis in the skeletal 
system (Table 3.2).  qPCR demonstrated that miR-9 and miR-199a were significantly 
reduced by 2-and 2.5-fold, respectively (Figure 3.2 D,E).  These data suggest that during 
cell differentiation, arsenic exposure increases miRNAs associated with pluripotency and 




Arsenic induced miR-466-669 cluster expression 
    Clustered microRNAs are usually co-expressed, and several studies have shown 
that they have a small but significant tendency to co-target the same genes and therefore 
jointly regulate specific molecular pathways (Hausser and Zavolan, 2014). As shown in 
Table 3.3, seven miRs in the miR-466/467/669 cluster were significantly induced in the 
arsenic-exposed cells, and five of them are increased by more than two-fold.  To verify 
the expression of these clustered miRNAs, qPCR was used.  All the miRNA 466/467/669 
family members are significantly induced in the arsenic exposed cells from 1.7- to 3.7-
fold, except miR-466i (Figure 3.3A).  Among those transcripts, miR-466g, -467d, -467a 
and -669p have more than 3-fold increase in day 9 cells exposed to arsenic.  
 
Arsenic induced the miR-466-669 cluster and its host gene, sfmbt2, in a time- 
dependent manner.  
    The miR-466/467/669 cluster is located on chromosome 2 within the 10
th
 intron 
of the Sfmbt2 gene.  Thus, the expression of the host gene was also assessed by qPCR, to 
see if co-regulation of Sfmbt2 and the miR-466-669 cluster existed. Indeed, on day 9, 
Sfmbt2 expression is induced 2-fold in the arsenic-exposed cells (Figure 3.3B). We 
further wanted to determine if the miRNA cluster and host gene expression patterns were 
similar during embryoid body formation and differentiation, so transcript levels from day 
0, 2, 5 and 9 were analyzed by real-time PCR.   The levels of miR-467d, miR-669p, and 
Sfmbt2 were dramatically induced by 11-, 40-, and 55-fold, respectively on day 2 of 
embryoid body formation as compared to the day 0 cells (Figure 3.3 C,D,E).  As time 
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goes on, expression of all three transcripts decreases in the control cells, while the levels 
remain higher and decline more slowly in the arsenic-exposed cells.  At all time points, 
the cells exposed to arsenic have significantly increased transcript expression of miR-
467d, miR-669p, and Sfmbt2. For example, at day 5, the highest point of transcript 
expression, miR-467d, miR-669p and sfmbt2 were induced by arsenic by 3-, 3- and 2-
fold, respectively (Figure 3.3C,D,E). Sfmbt2 and miR-467d and miR-669p showed the 
similar pattern of expression, indicating that Smbt2 induction likely drives the expression 
of this miRNA cluster.  
 
Induction of miR-466-669 cluster is specific to stem cells  
    In our model of differentiation, P19 stem cells can differentiate into neurons and 
skeletal myotubes.  Thus, we sought to determine if the miR-466-669 cluster played a 
role in specific cell lineages. We evaluated the expression of this miRNA cluster in the 
C2C12 myoblast cell line, which can be induced to differentiate into skeletal myotubes 
and in Neuro2A neuroblast cells, which can differentiate into neurons.  Our lab has 
previously shown that 20nM arsenite inhibits the differentiation of C2C12 cells (Steffens 
et al., 2011).  Neuro2A cells exposed to 1µM and 2.5µM of arsenite during 
differentiation also show decreased neuron formation (Figure S3.1), which consistent 
with other studies (Wang et al., 2010).  Both cell lines were exposed to arsenic in either 
growth medium or differentiation medium, and RNA was extracted.  miR-466g, -467d, 
and -669p expression did not change when the cells were undergoing differentiation 
(Figure 3.4A,C) nor when they were simply proliferating (Figure 3.4B,D).  Likewise, the 
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levels of these miRs did not change when the cells were exposed to arsenic (Figure 3.4).  
These results suggest that the induction of miR-466/467/669 cluster expression controls 
lineage commitment earlier in the cell differentiation process. 
 
miR466-669 cluster members share multiple consensus sequences  
   In order to determine sequence similarity, we used all mature miRNA sequences 
within this cluster from the updated miRBase Sequence Database (version 21) to perform 
multiple sequence alignment by Clustal Omega. The cluster sequences included 26 
mature miRNA sequences in the miR-466 family, 13 sequences in the miR-467 family, 
and 26 sequences in the miR-669 family.  A total of 24 miRNA-3p members have high 
degree of similarity, as shown in its consensus sequence (Figure 3.5A).  This first 
consensus sequence is modified from another study which aligned all miRNA-3p 
members together (Luo et al., 2014). Interestingly, 15 of the -3p members share the seed 
sequence, UAUACAU, even those are in different subfamilies (Figure 3.5A).  The 
miRNAs-5p members clustered together, but did not have the same degree of similarity 
to each other.  So these were subdivided into 3 additional clusters with miR-466 (h-
5p/j/m-5p) grouping together (Figure 3.5B), miR-467(c/e/g/d/a/b-5p) grouping together 
(Figure 3.5C), and miR-669 (c/n/e/b/f/d/a/l/o-5p) grouping together (Figure 3.5D). These 





Inhibition of the miR-466-669 cluster rescues the inhibitory effects of arsenic on 
stem cell differentiation 
   To evaluate the effects of the miR-466-669 families on stem cell differentiation 
and its inhibition by arsenic, consensus anti-miRs targeting consensus sequence 1, 2,3, 
and 4 (Figure 3.5) were added during cell differentiation from day 0 to day 5, when cells 
were cultured with or without 0.5 μM arsenic. A portion of day 5 embryoid bodies were 
harvested for marker gene determination and the rest were grown out to day 9 to observe 
morphological changes. The 4 individual consensus sequence anti-miRs did not rescue 
the arsenic-mediated reduction in cellular differentiation (Figure 3.6C-J), as few neurons 
and myoblasts were observed.  The lack of morphological rescue was confirmed by the 
lack of Pax3 expression changes (Figure 3.7 A-B).  However, when cells were transfected 
with all four consensus inhibitors, there was a rescue effect, in that cells exposed to 
arsenic differentiated into neuronal and muscle cells (Figure 3.6L). Pax3 expression was 
also recovered by the anti-miR mix (Figure 3.7C).  
In order to verify if miRNAs were also knocked down by inhibitors, we designed 
primers for these consensus sequences. As shown in figure 3.7, only consensus sequence-
1 (Figure 3.7D) and 3 (Figure 3.7F) are significantly induced by arsenic, indicating that 
only those two subfamilies are involved in arsenic-induced effects.  Notably, the induced 
expression by arsenic was knocked down to the unexposed level when treated with 
inhibitors (Figure 3.7D, F). To determine if the inhibitory effects are due to the miRNAs 
themselves or their host gene, we collected day 5 transfected cells and determined Sfmbt2 
expression by qPCR. Arsenic induced Smbt2 expression whether or not the anti-miRs 
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were added, suggesting that the host gene itself is not involved in the differentiation 
process nor is its expression inhibited by the anti-miRs (Figure 3.7H).    
 
Discussion 
   The present study demonstrates that arsenic can alter miRNA expression, 
including miR-9, miR-92a, miR-199a, miR-291a, miR-709, and the miR-466-669 cluster, 
which leads to the repression of P19 embryonic stem cell differentiation. This study 
highlights the role microRNAs play in arsenic-mediated repression of stem cell 
differentiation and ascribes a novel function for the miR-466-669 cluster in embryonic 
stem cells.  
Several studies report that arsenic alters miRNA expression. For example, 
exposure of bladder or liver cell lines to 5 μM arsenic trioxide (ATO) can reduce miR-
19a and miR-29a expression, which inhibits cell proliferation and induces apoptosis (Cao 
et al., 2011;  Meng et al., 2011). Neither one of these miRs is expressed in our embryonic 
stem cells.  Chronic exposed to 1μM sodium arsenite for 26 weeks induced 
transformation in lung epithelial cells and miR-199a was significantly reduced in 
transformed cells, suggesting the roles of miR-199a in carcinogenesis (He et al., 2014). 
Interestingly, the reduction of miR-199a is consistent with our expression data, which 
may indicate that miR-199a expression is simply be indicative of arsenic exposure or of a 
de-differentiation process of the lung cells.  Exposure of chick embryos to 100 nM 
arsenite reduced miR-9 and miR-181b, which target neuropilin-1(Nrp1) to induce 
angiogenesis (Cui et al., 2012).  According to our microarray data, miR-181b levels are 
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fairly high and are reduced slightly by arsenic, but this is not statistically different.  As 
measured by the arrays and by qPCR, miR-9 is significantly reduced by 2- to 3-fold in 
arsenic exposed embryoid bodies. miR-9 is known to be induced during neural lineage 
differentiation, and its inhibition blocks neurogenesis in embryonic stem cells 
(Krichevsky et al., 2006). This indicates that miR-9 plays an important role during 
embryonic development and reduction by arsenic might be involved in the inhibitory 
effects seen in our study.    
miRNAs can regulate specific gene expression during different development 
stages and in different cell types.  In mouse embryonic stem cells, miR-134, miR-296 and 
miR-470 are induced during differentiation because they target three critical transcription 
factors, Nanog, Oct-4 and Sox2, which are downregulated when cells undergo 
differentiation (Tay et al., 2008).  In our day 9 cells, miR-470 is not expressed, and while 
the levels of miR-134 and miR-296 are not changed when exposed to arsenic, they are 
only expressed at low levels. Because we plate the embryoid body on day 5 and allow 
cells to proliferate and differentiate away from it during the next 4 days of differentiation, 
part of the initial embryoid body, consisting of undifferentiated cells, remains.  Indeed, 
we can still see the stem cell marker Nanog being expressed in the center of the embryoid 
body (Hong and Bain, 2012).  While we definitely see changes in miR expression, the 
levels of transcript may be diluted out because of the mixed population of cells. 
During skeletal muscle formation, many miRNAs control the core myogenic 
transcriptional network, including miR-1, -27, -133, -206, -208, and -486 (Braun and 
Gautel, 2011).   Increased expression of miR-1, -27b, and -206 can bind to and inhibit 
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Pax3 expression in myoblast cells (Crist et al., 2009).  In our day 9 cells, miR-1 is not 
expressed and miR-206 is expressed, but at very low levels. miR-27b is increased by 1.4-
fold (p=0.1), which may be suggestive of Pax3 inhibition.  Because these miRs were 
discovered in myoblast cells, the lack of concordance may suggest that these miRs 
regulate further stages of differentiation, from myoblasts to myotubes.  The miR-290 
cluster is important in maintaining stem cell pluripotency and inhibiting embryonic stem 
cell differentiation (Sinkkonen et al., 2008). Interestingly, several members of miRNA-
290 cluster were induced by arsenic in our microarray, including a 4-fold induction of 
miR-291a and miR-291b, a 2-fold induction of miR-290a, a 2.8-fold induction of miR-
292a, and a 4.7-fold fold induction of miR-294.  We further determined the time-
dependent expression of the most significantly induced family member, miR-291a by 
qPCR.  As the cells were undergoing differentiation, miR-291a levels decreased by 3.2-
fold on day 5 and 4-fold on day 9.  However, arsenic exposure kept miR-291a at nearly 
the same levels as in day 0 stem cells (Figure S3.2). This indicates that cellular 
pluripotency is maintained when cells are exposed to arsenic. However, the exact 
mechanisms by which arsenic can induce the miR-290 cluster expression still remains to 
be uncovered.     
  The miRNA 466-669 cluster is one of the largest miRNA clusters in mice and 
rats, and is located in the 10th intron of the Sfmbt2 gene, a polycomb group protein 
(Lehnert et al., 2011). There are few investigations on the function of this cluster.  miR-
466h is induced in Chinese hamster ovary cells treated with nutrient-depleted media, 
which induces apoptosis (Druz et al., 2011). Another study demonstrated that miR-466h 
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is increased due to the downregulation of HDAC activity in its promoter region, caused 
by low glucose-derived oxidative stress (Druz et al., 2012).  miR-467a can promote the 
growth and survival of mouse ES cells by targeting Lats2 and Dedd2, which are well 
conserved inducers of apoptosis (Zheng et al., 2011).  These investigators predicted a 
number of genes that were targets for the entire cluster (Zheng et al., 2011).  We 
examined several of their top predicted genes, ones that are related to cell differentiation 
pathways and histone modification, including Hdac4, Myst4, Hes6, Fzd1, and Fzd7, in 
day 5 and day 9 arsenic-treated P19 cells by qPCR. However, none of them were 
significantly changed by arsenic (data not shown), nor were the expression of Hdac4 and 
Myst4 altered when the cells were exposed to miR-466-669 cluster inhibitor (data not 
shown). These results suggest that arsenic does not target these genes, nor do specific 
clusters members target Hdac4 or Myst4.  
Additionally, when mouse medullary epithelial cells were exposed to high sodium 
chloride levels, the increased levels of miR-466(a/e)-3p bound to and down-regulated 
renal Nfat5, an osmoresponsive transcription factor (Luo et al., 2014). Although arsenic 
exposure has not been associated with hypertonic stress, arsenic has been reported to 
inhibit histone deacetylase activity (Ramirez et al., 2008). Therefore, arsenic’s effects on 
the miR-466-669 cluster might be due to epigenetic regulation. We did examine H3K9 
acetyl and dimethyl marks on several regulatory regions of the cluster. However, there is 
no was no detectable acetylation and arsenic exposure did not alter H3K9 methylation 
(Figure S3.3).  These results suggest that the induction of the miR-466-669 cluster by 
arsenic is not due to histone modification on its promoter region. 
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In a previous study, we determined that arsenic inhibited the Shh signaling 
pathway by decreasing Gli2 expression and activity in P19 cells (Liu and Bain, 2014).  
Thus, Gli2 transcript levels were examined cells exposed to anti-miRs targeting the miR-
466-669 cluster exposed with or without arsenic. Interestingly, Gli2 expression was 
increased almost back to control levels when the miR-466-669 cluster was inhibited 
(Figure S3.4).  There is no evidence showing that this cluster directly target Gli2 gene or 
decrease Gli2 activity. By comparing the consensus sequence and Gli2 mRNA 3’UTR 
region and based on the algorithm from Zheng’s study, Gli2 is not the predicted target of 
miR-466-669 cluster (Zheng et al., 2011). However, Gli2 expression is regulated by other 
signaling pathways, including TGF-β and Wnt (Borycki et al., 2000;  Dennler et al., 
2007). Based on the prediction algorithm from Zheng’s study, Wnt4 has been predicted 
as the target of miR-466-669 cluster (Zheng et al., 2011). This suggests that miR-466-669 
might act upstream of Shh signaling pathway, although more studies are needed to see 
whether this signaling is regulated directly or indirectly by the cluster.  
   Collectively, our results indicate that low-level arsenic exposure to P19 
embryonic stem cells during their differentiation alters the expression profile of miRNAs, 
including several development related miRNAs.  Specifically, members of miRNA-466-
669 cluster were significantly induced by arsenic, but this induction did not occur in 
myoblast or neuroblast cells.  The host gene Sfmbt2 was also induced by arsenic a time-
dependent manner, which is consistent with the cluster expression.   However the 
acetylation and methylation status on its promoter region is not changed, indicating that 
induction is not due to changes in histone modification.  Interestingly, the inhibition of 
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the whole cluster rescued the inhibitory effects of arsenic, although the further studies are 
needed to uncover potential target genes for this cluster, such as Gli2.  Our results 
indicate that the miR-466-669 cluster plays a role in stem cell differentiation and is also a 
target of arsenic effects.   
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Table 3.1. Primer sequences  
 
Gene Name Forward Reverse
miR-9 ATA AAG CTA GAT AAC CGA AA
miR-92a TAT TGC ACT TGT CCC GGC CTG
miR-199a ACA GTA GTC TGC ACA TTG GTT A
miR-291a CAT CAA AGT GGA GGC CCT CT
miR-466b CCA AGC CAA CTT TAT GTC AGG G
miR-466f ATC AGC CAA CCA AGA GAC AGC AGA
miR-466g GCC TCT GAG CAC AGA AAG TCA TCA
miR-466h AAA GAA CTG CGG CAA GTT TTT G
miR-466i GCC AAG CAA CCT GCT GAA AGT CTA
miR-467a CAT ATA CAT ACA CAC ACC TAC A
miR-467d ATA TAC ATA CAC ACA CCT ACA C
miR-669c TAC ACA CAC ACA CAC AAG TAA A
miR-669e TGA ATA TAC ACA CAC TTA CAC
miR-669f CAT ATA CAT ACA CAC ACA CGT AT
miR-669p CATAACATACACACACACACGTAT
miR-709 GGA GGC AGA GGC AGG AGG A
U6 TGG CCC CTG CGC AAG GAT G
Consensus-1 TAT ACA TAC ACA CAC ACA CAT A
Consensus-2 TGT GTG CAT GTG CAT GTG TGT A
Consensus-3 TAA GTG CGT GCA TGT ATA TG
Consensus-4 AGTT GTG TGT GCA TGT GTA T
Sfmbt2 AAG ATA ACC GGC TCA GCA AAT G TCT CTT CCA AAT AGT CTC CCC AG
Gapdh TGC GAC TTC AAC AGC AAC TC ATG TAG GCC ATG AGG TCC AC
Pax3 CCT CTG CCC AAC CAT ATC CG GAA ATG ACG CAA GGC CGA ATG
ChIP #1 GTA GAC TTG GTG AGT TAG AAG GCT GTG TGC AAT CTT CTC TTT CCA AGG
ChIP #2 GTG GCT GGT GGA CTG ATA AA TAG GCA GCA GAA CTC CTT TG 
ChIP #3 TGC TTT GCG CTT GGT TAT TG CCC AAC TTA CCT CTT CTC ACT C 
ChIP #4 CTT GTG GGT CTA AGC CTC TAA A CCT CTT CTC ACT CCT TCA ACT C
ChIP #5 GGA ACC ACG TGT GGG AAT TT CAC CTA TCC CTT ACA CCA CTC T
Universal Reverse Primer
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Table 3.2. Developmentally-related miRNAs significantly changed by arsenic during 




Table 3.3. miR-466/467/669 cluster expression  in differentiating P19 cells with or 
without arsenic exposure 
 
miRNA Fold Change (control/As) p-value 
miR-669f-3p 2.45 0.013 
miR-466g 2.08 0.015 
miR-669p-3p 1.87 0.015 
miR-467a-3p 2.73 0.030 
miR-467d-3p 2.60 0.038 
miR-466f-5p 1.87 0.038 
miR-669e-3p 2.81 0.045 
miR-466i-3p 1.93 0.061 
miR-466b-3p 1.36 0.073 












miR-92a Up regulated Highly expressed in induced pluripotent 
and embryonic stem cells 
(Wilson et al., 
2009) 
miR-291a Up regulated Promotes pluripotency maintenance in 
mouse embryonic stem cells 
(Lichner et al., 
2011) 
miR-709 Up regulated Inhibits adipocyte differentiation through 
targeting GSK3 




 Induced during neuronal cell 
differentiation  




Induced during embryonic development 
and regulates chondrogenesis 
(Lee et al., 


































































Figure 3.1.  Expression profiles of miRNAs between control and arsenic exposure in 
differentiating P19 cells.  
P19 cells were induced to differentiate with or without 0.5 µM of arsenic for 9 days.  
miRNA expression was detected via a miRNA microarray and plotted as a heat map. 
Green indicates reduced expression due to arsenic and red indicates increased expression. 
Only statistically different expression (Student’s t-test; p-value < 0.05) are listed in the 
map. The miRNAs with similar expression signals and fold-changes are clustered 


























































































Figure 3.2. Validation of miRNA transcript levels by qPCR.  
Day 9 differentiated P19 cells were used to confirm miRNA expression by qPCR (n=3 
per treatment). Significantly changed miRNAs with known roles in development were 
examined (Table 2), including miR-92a (A), miR-291a (B), miR-709 (C), miR-199a (D), 
and miR-9 (E). Expression values were normalized with U6 snRNA and fold differences 
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calculated from control cells using the delta Ct method. Values are expressed as mean ± 

























































































































Figure 3.3.  Arsenic exposure induces members of the miR-466-669 cluster along 
with its host gene, Sfmbt2.  
P19 cells were differentiated and RNA was extracted from cells exposed to 0 or 0.5 μM 
arsenite on days 0, 2, 5, 7, and 9 (n=3 per treatment per day).  miRNA or mRNA 
expression was determined by qPCR.  Day 9 samples were used to determine the 
expression of miRNA-466-669 cluster genes (A) and the host gene Sfmbt2 (B).  Samples 
from days 0, 2, 5, 7, and 9 were used to determine the expression of miR-467d (C), miR-
669p (D), and Sfmbt2 (E).  Expression values were normalized with U6 snRNA for the 
miRNAs, and Gapdh for Sfmbt2.  Fold changes were compared to unexposed cells, and 
time-dependent qPCR expression fold changes were compared to day 0 unexposed cells.  
Data is shown as mean ± S.D. Statistical differences were determined by ANOVA 


















































































Figure 3.4.  Arsenic does not alter expression of the miR-466-669 cluster in C2C12 
and N2A cells.   
C2C12 myoblast cells were exposed to 20 nM arsenite in growth medium (GM) or 
differentiation medium (DM) for 4 days (n=3 replicates per treatment) (Figure A-B).  
Neuro2A neuroblast cells were exposed to 1 μM or 2.5μM arsenite in growth medium 
(GM) or differentiation medium (DM) for 2 days (n=3 replicates per treatment) (Figure 
C-D).  qPCR was used to determine the expression of miR-466g, miR-467d, and miR-
669p.  All expression values were normalized with shRNA U6 and fold changes were 
compared to unexposed cells. Data is shown as mean ± S.D., and statistical differences 
were determined by ANOVA followed by Tukey’s test (*; p<0.05). 
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mmu-miR-466h-5p      UGUGUGCAUGUGCUUGUGUGUA- 
mmu-miR-466j         UGUGUGCAUGUGCAUGUGUGUAA 
mmu-miR-466m-5p      UGUGUGCAUGUGCAUGUGUGUAU 
                     ************* ********  
CONSENSUS-2          UGUGUGCAUGUGCAUGUGUGUA 
mmu-miR-467c-5p      -UAAGUGCGUGCAUGUAUAUGUG 
mmu-miR-467e-5p      AUAAGUGUGAGCAUGUAUAUGU- 
mmu-miR-467h         AUAAGUGUGUGCAUGUAUAUGU- 
mmu-miR-467d-5p      -UAAGUGCGCGCAUGUAUAUGCG 
mmu-miR-467a-5p      -UAAGUGCCUGCAUGUAUAUGCG 
mmu-miR-467b-5p      GUAAGUGCCUGCAUGUAUAUG-- 
                      ******   ***********  
CONSENSUS-3           UAAGUGCGUGCAUGUAUAUG 
mmu-miR-669c-5p      AUAGUUGUGUGUGGAUGUGUGU---- 
mmu-miR-669n         --AUUUGUGUGUGGAUGUGUGU---- 
mmu-miR-669e-5p      UGUCUUGUGUGUGCAUGUUCAU---- 
mmu-miR-669b-5p      --AGUUUUGUGUGCAUGUGCAUGU-- 
mmu-miR-669f-5p      --AGUUGUGUGUGCAUGUGCAUGUGU 
mmu-miR-669d-5p      --ACUUGUGUGUGCAUGUAUAUGU-- 
mmu-miR-669a-5p      --AGUUGUGUGUGCAUGUUCAUGUCU 
mmu-miR-669l-5p      --AGUUGUGUGUGCAUGUAUAUGU-- 
mmu-miR-669o-5p      -UAGUUGUGUGUGCAUGUUUAUGU-- 
                         ** ****** ****   *     




mmu-miR-669e-3p        ---UGAAUAUACACACACUUACAC------ 
mmu-miR-466g           ----AUACAGACACAUGCACACACA----- 
mmu-miR-466f-3p        -------CAUACACACACACAUACACAC-- 
mmu-miR-466i-3p        --------AUACACACACACAUACACACUA 
mmu-miR-466o-3p        -----UACAUACAUGCACACAUAAGAC--- 
mmu-miR-466d-3p        ---UAUACAUACACGCACACAUAG------ 
mmu-miR-466a-3p        ---UAUACAUACACGCACACAUAAGA---- 
mmu-miR-466l-3p        ---UAUAAAUACAUGCACACAUAUU----- 
mmu-miR-466b-3p        ----AUACAUACACGCACACAUAAGA---- 
mmu-miR-669c-3p        -----UACACACACACACACAAGUAAA--- 
mmu-miR-669p-3p        -CAUA-ACAUACACACACACACGUAU---- 
mmu-miR-669a-3p        ACAUA-ACAUACACACA--CACGUAU---- 
mmu-miR-669l-3p        --AUAUACAUACACACC--CAUAUAU---- 
mmu-miR-669d-2-3p      --AUAUACAUACACACC--CAUAUAC---- 
mmu-miR-669d-3p        ---UAUACAUACACACC--CAUAUAC---- 
mmu-miR-467g           ---UAUACAUACACACA--CAUAUAU---- 
mmu-miR-467f           --AUAUACACACACACA--CCUACA----- 
mmu-miR-467e-3p        --AUAUACAUACACACA--CCUAUAU---- 
mmu-miR-467c-3p        --AUAUACAUACACACA--CCUAUAC---- 
mmu-miR-467b-3p        --AUAUACAUACACACA--CCAACAC---- 
mmu-miR-467a-3p        -CAUAUACAUACACACA--CCUACA----- 
mmu-miR-467d-3p        --AUAUACAUACACACA--CCUACAC---- 
mmu-miR-669f-3p        -CAUAUACAUACACACA--CACGUAU---- 
mmu-miR-669b-3p        -CAUAUACAUACACACA--AACAUAU---- 
mmu-miR-669m-3p        --AUAUACAUCCACACA--AACAUAU---- 
                                *  *** 
Consensus-1               UAUACAUACACACACACAUAUA       
Figure 3.5. The miR-466-669 cluster share sequence similarities. 
Sequences of mature miRNA from the miR-466-669 cluster were aligned using Clustal 
Omega. All mature sequences were initially aligned together and then were subdivided 
into four major groups which have high similarity. The highlighted nucleotides were used 
to derive the consensus sequences (as light blue).   An asterisk indicates the sequence 
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Figure 3.6. Inhibiting the miR-466-669 cluster during P19 cell differentiation.  
P19 cells were transfected with 100 nM anti-miRNA oligonucleotides which target 4 
individual consensus sequences of the miRNA-466/467/669 cluster.  Cells were co-
exposed to 0 or 0.5 μM arsenic for the 5 days of embryoid body formation.  Only the 
arsenic exposure was maintained for the entire 9 days of differentiation, after which cell 
morphology was observed. Transfections include oligonucleotides sequences that do not 
target any miRNAs, designated as negative control, (A-B), consensus-1 (C-D), 
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consensus-2 (E-F), consensus-3 (G-H), consensus-4 (I-J), and mixed transfection that 
combined all consensus anti-miRs (K-L). Arrows indicate neuronal cells and arrow heads 















































































































































Figure 3.7. Mixed miRNA inhibitors rescue rescues arsenic’s inhibitory effects on 
cell differentiation. 
   P19 cells were transfected with miRNA inhibitors, with or without 0.5 μM arsenic (n=3 
replicates per anti-miR and per exposure group), and allowed to form embryoid bodies 
for 5 days.  A portion of the day 5 embryoid bodies was collected for RT-qPCR.  Pax3 
expression, an early differentiation marker gene, was determined in the cells transfected 
individually with the consensus anti-miRs (A-B) or transfected with a combined mixture 
of the 4 anti-miRs (C).  Rescue of the four individual consensus sequences and the 
mixture were assessed by qPCR (D-G), as was the effect on the host gene, Sfmbt2 (H).  
mRNA expression levels were normalized with Gapdh and miRNA expression levels 
were normalized with shRNA U6 using the comparative delta Ct method.  Fold changes 
were compared to negative control (NC).  Data is shown as mean ± S.D., and statistical 




















Figure S3.1. Arsenic exposure decreased Neuro2A cell differentiation.  
Neuro2a neuroblastoma cells were cultured in DMEM medium with 10% fetal bovine 
serum (growth medium) with or without 1 and 2.5 μM sodium arsenite for 48 hours (A-
C). To induce differentiation, growth medium was replaced with DMEM medium 
containing 2% fetal bovine serum and 20 μM all-trans retinoid acid (differentiation 
medium), with or with or without 1 and 2.5 μM sodium arsenite for 48 hours (D-F).  


























Figure S3.2. miR-291a was upregulated when exposed to arsenic during cell 
differentiation. 
P19 cells were differentiated and RNA was extracted from cells exposed to 0 or 0.5 μM 
arsenite,on days 0, 5, and 9 (n=3 per treatment per day).  miR-291a expression was 
determined by qPCR.  Expression values were normalized to U6 snRNA, and fold 
changes were compared to day 0 unexposed cells.  Data is shown as mean ± S.D. 


































































































Figure S3.3. Histone modification status in the promoter region of Sfmbt2 and miR-
466-669 cluster is not changed when exposed to arsenic. 
Day 5 embryoid bodies with or without arsenic exposure were harvested for ChIP assay.  
A schematic diagram of Sfmbt2 and the miR-466-669 cluster promoter region shows the 
predicted promoter site (Marson et al., 2008), CpG island, transcription start site and the 
location of ChIP assays (A).  ChIP assays were performed with antibodies against di-
methylated H3K9 (H3K9 Me2), and acetylated H3K9 (H3K9 Ac) histones.  Enriched 
DNA fragments from the ChIP assays were analyzed by qPCR, and are expressed as a 
percentage of input. The values from replicate experiments were plotted as the mean ± 
S.D. (n=3) and statistical differences were determined by ANOVA followed by Tukey’s 
















Figure S3.4. Mixed miRNA inhibitors rescue arsenic’s inhibitory effects on Gli2 
expression. 
P19 cells were transfected with all four miRNA inhibitors, with or without 0.5 μM 
arsenic (n=3 replicates per exposure group), and allowed to form embryoid bodies for 5 
days.  A portion of the day 5 embryoid bodies was collected for RT-qPCR.  Gli2 
expression was determined by qPCR, and transcript levels normalized with Gapdh using 
the comparative delta Ct method.  Fold changes were compared to negative control (NC).  
Data is shown as mean ± S.D., and statistical differences were determined by ANOVA 













Previous studies in our laboratory have shown that arsenic represses neurogenesis 
and myogenesis in P19 embryonic stem cells (Hong and Bain, 2012). Therefore, the goal 
of the present study was to discover the mechanisms by which arsenic reduces embryonic 
stem cell differentiation.  Our results from Chapter 2 indicate that arsenic inhibits the 
sonic hedgehog (Shh) signaling pathway during cell differentiation. The expression of the 
critical transcription factor Gli2 is reduced at both the mRNA and protein level, leading 
to its reduced transcriptional activity when exposed to arsenic. Treatment with exogenous 
Shh can rescue the inhibitory effects by arsenic on cell differentiation. In Chapter 3, we 
further discovered that specific microRNAs are altered by arsenic during P19 cell 
differentiation. Several members of miRNA-466-669 cluster, along with the host gene 
Sfmbt2, were significantly induced by arsenic in a time-dependent manner.  Moreover, 
this induction is specifically in embryonic stem cells, and inhibition of this cluster can 
rescue the inhibitory effects caused by arsenic. Taken together, the inhibition effects on 
cell differentiation by arsenic is due to the repression of transcription factor Gli2. Even 
though the inhibition mechanism of Gli2 is unknown, we found that arsenic induces the 
expression of miR-466-669 cluster, which regulates Gli2 expression directly or indirectly, 
leading to the inhibition of cell differentiation.      
Epidemiological studies have shown that arsenic causes developmental toxicity, 
in that children exposed in utero to arsenic have lower intelligence quotient scores, 
alterations in verbal learning, and decreases in long term memory (Jiménez-Capdeville 
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and Giordano, 2003).  Arsenic exposure also reduced birth weight and weight gain 
(Hopenhayn et al., 2003).  When conducting our experiments examining stem cell 
differentiation, we wanted to use arsenic levels similar to that which an embryo might be 
exposed to.  While there is limited available exposure data, a study in Argentina shows 
that mothers exposed to ≤ 200 ppb arsenic in their drinking water had 34 μg/kg arsenic in 
their placentas and 9 μg/L arsenic in cord blood (Concha et al., 1998). Because 
embryonic exposure levels should reflect the amount of arsenic in cord blood and 
placentas, rather than in drinking water, our study exposed P19 embryonic stem cells to 
levels of arsenic ranging from 7.5 to 37.5 μg/L. In vivo, inorganic arsenic can be 
transformed into methylated metabolites, including monomethylarsonic acid (MMAIII) 
and dimethylarsinic acid (DMAIII).  Although we have previously shown that As3MT is 
robustly expressed in P19 cells, we have not determined the amount of methylated 
arsenical species formed in P19 cells when exposed to inorganic arsenite.  However, 
another study from our laboratory indicates that MMAIII and DMAIII repress cell 
differentiation and reduce myogenic and neurogenic transcription factor expression in a 
manner similar to inorganic arsenite, albeit at lower concentrations, which suggests that 
exposure of P19 cells to inorganic arsenic should still be reflective of an in vivo exposure 
scenario (McCoy et al., 2015). Studies have shown that maternal exposure to 100 ppb of 
arsenic via drinking water results in urinary arsenic levels that are 43% DMA, 31% 
MMA, and 26% iAs (Hall et al., 2007). Since the methylated species impair 
differentiation at lower concentrations than inorganic arsenic, in vivo exposures might be 
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more toxic and detrimental to embryonic development than our study reveals, since there 
would be more methylated metabolites of arsenic present.  
Several in vivo studies have looked into the gene and signaling pathways altered 
by arsenic embryonic development and fetal growth.  For example, a study determining 
expression of several key developmental genes in human placenta from an in utero 
arsenic exposure found out that Gli3 expression was negatively associated with arsenic 
exposure and positively associated with infant birth weight (Winterbottom et al., 2015).  
Another study exposing mice to 50 ppb arsenic during pregnancy found out that 
glucocorticoid signaling in the brain was disrupted by reducing the enzyme 11β-HSD 
expression during embryonic day 14, which plays a critical role of learning and memory 
(Caldwell et al., 2015). These studies suggest that arsenic alters signaling pathway in 
vivo, leading to the dysfunction of organism.  In order to elucidate the mechanism by 
which arsenic affects signaling, several in vitro studies have determined the effects on 
apoptosis pathways, oxidative stress pathways (Chattopadhyay et al., 2002;  Cheung et 
al., 2007;  Martinez et al., 2011). Moreover, signaling pathways related to cell growth 
such as Akt, Ras, ERK, JNK and p38 pathways are also altered when exposed to arsenic 
(Liu et al., 1996;  Souza et al., 2001). To our knowledge, our study is one of the few 
which is examining arsenic’s effects on developmentally-important signaling pathways.  
In order to elucidate the main pathway targeted by arsenic, we first examined key 
proteins in the Notch, Bmp4, Fgf, and Shh signaling pathways.  Previous studies in our 
laboratory have indicated that arsenic can modulate -catenin transcript and nuclear 
localization during stem cell differentiation, which works via the Wnt signaling pathway 
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(Hong and Bain, 2012).  Our preliminary experiments indicated than in addition to Wnt, 
arsenic can down-regulate the expression of Gli2, thus inhibiting the Shh signaling 
pathway. The Shh signaling pathway has been shown to induce the expression of several 
genes of the myogenic regulatory factor family including, Pax-3, MyoD, and myogenin 
(Duprez et al., 1998). It also induces neurogenic bHLH factors such as NeuroD, Neurog1, 
and Ascl1 (Voronova et al., 2011). In addition to the changes in Gli2 expression, we also 
examined other Shh signaling proteins such as the expression of Smo, Sufu and Ptch1, 
the phosphorylation and cleavage of GLI2, and its localization within the primary cilium, 
but none of these were altered by arsenic. Therefore, our study indicates that decreased 
expression of those neuronal or myogenic transcription factors by arsenic might be due to 
the inhibition of Shh signaling via Gli2.  However, why arsenic specifically reduces this 
signaling pathway, as opposed to other pathways, is still unknown. There are other 
signaling pathways that help to regulate Gli2 expression. During somite formation, Wnt 
signaling was shown to induce Gli2 expression (Borycki et al., 2000), and in several 
human cell types, TGF-β induces Gli2 independent from Shh receptor signaling (Dennler 
et al., 2007). Therefore, studying further upstream pathways can help us elucidate how 
arsenic inhibits Gli2 expression.   
Since several studies show that microRNAs inhibit Shh signaling, we 
hypothesized that alterations in developmentally-important signaling pathways are due to 
changes in miRNA expression (Ferretti et al., 2008;  Katoh and Katoh, 2008).  Based on 
our miRNA microarray data, none of the miRNAs reported in the literature to regulate 
Shh signaling, including miR-125b, miR-324 and miR-214, were altered by arsenic.  
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However, several other miRNAs were changed, including miR-9, miR-92a, miR-199a, 
miR-291a and miR-709, all known to be involved in stem cell pluriopotency maintenance 
or muscle and/or neuronal cell differentiation (Chen et al., 2014;  Lee et al., 2009;  
Lichner et al., 2011;  Wilson et al., 2009;  Zhao et al., 2009).  Changes in these specific 
miRNAs validate that arsenic is indeed working to impair stem cell differentiation, rather 
than proliferation.  We chose to focus our further studies on a novel set of microRNAs, 
the miR-466-669 cluster.  This cluster has 65 members within intron 10 of the host gene 
Sfmbt2 (Lehnert et al., 2011), and of the 65 members on the microRNA array used, 20 of 
these genes were increased by 1.5-to 4-fold.  This study further determined that the use of 
4 consensus anti-miRs together, that should inhibit 60 % of the cluster, can effectively 
rescue the inhibitory effects by arsenic.  While the exact function of the miR-466-669 
cluster is not known, other studies have determined that it can regulate osmoregulation 
and urine concentration in mice (Luo et al., 2014).  
Interestingly, Gli2 transcript levels are also recovered when knocking down the 
miR-466-669 cluster.  Arsenic reduces Gli2 expression by 2.5-fold and the consensus 
anti-miRs bring the expression back up to 0.9-fold of control.  These data suggest that the 
arsenic’s induction of the miR-466-669 cluster can directly or indirectly regulates Gli2 
expression. This is also supported by the time-dependent expression data in P19 cells 
which shows that Gli2 expression starts at day 5, and miRNA-466-669 cluster expression 
starts to decrease at day 5. However, by comparing the consensus sequences with the 
Gli2 3’UTR, and using the algorithm from Zheng’s study, Gli2 is not the predicted target 
of miR-466-669 cluster (Zheng et al., 2011). Therefore, we hypothesize that the miR-
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466-669 cluster might act upon a protein upstream of Gli2. As mentioned above, two 
other signaling pathways, Wnt and Tgf-β, can regulate Gli2 expression.  Wnt4 is 
predicted as a possible target of the miR-466-669 cluster (Zheng et al., 2011).  Therefore, 
studying the effects of the cluster upstream of Gli2 is something that should be done in 
future studies.  In conclusion, it appears that arsenic repressed the sonic hedgehog 
signaling pathway, and induced expression of the  miR-466-669 cluster, which may both 
work together to inhibit stem cell differentiation.   
Ultimately, our data should be useful to determine whether the current drinking 
water standard for arsenic, 10ppb, is protective of embryonic health, and whether a 
standard for arsenic in foods, such as rice, needs to be set.  As part of setting these 
standards, cells are often exposed to the toxicant of interest and then examined for 
morphological changes, such as proliferation (Vega et al., 2001).  Because low levels of 
toxicants may not show significant morphological effects, and because many times only 
proliferation, rather than differentiation, is assessed, the use of these data for risk 
assessment is often difficult (Gibb et al., 2011).  Recently, researchers are trying to 
develop better toxicity assessment methods using cell lines to quickly screen chemicals.  
National programs such as Tox21 from NIEHS and ToxCast from EPA screen chemicals 
using a variety of differentiated human cell lines to examine reporter gene activity, gene 
expression, kinase/protease activity, and G-protein coupled receptor signaling.  Work 
incorporating mouse stem cell differentiation screening assays is being finally conducted 
under this program (Sipes et al., 2013).  Other investigators outside of EPA and NIEHS 
are also using stem cell differentiation assays as screening tools to identify developmental 
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toxicants (Palmer et al., 2013).  Therefore, studies using mouse embryonic stem cells 
appears to be gaining favor as a model to perform chemical assessments for development 
toxicity.   In addition, our miRNA microarray data provides a list of miRNAs whose 
expression level are affected by arsenic treatment, which can serve as potential 
biomarkers of arsenic effect with useful value for risk assessment on developmental 
toxicity.  
Several studies indicate that low levels of arsenic exposure increase the risk of 
carcinogenesis by inducing the sonic hedgehog signaling pathway (Fei et al., 2010;  
Tokar et al., 2010).  However, our study shows that arsenic impairs Shh signaling during 
development and cell differentiation.  The results of our study may be useful when 
thinking about potential therapies for arsenic-induced developmental defects.  For 
example, Shh gene therapy has been shown to increase skeletal and cardiac muscle 
regeneration after injury (Kusano et al., 2005;  Piccioni et al., 2014).  The sonic 
hedgehog pathway agonist SAG has also been used to rescue the phenotypes associated 
with hippocampal deficits in mice, leading to the improvement of learning and memory 
behavior (Das et al., 2013). The results of our study may provide a potential therapeutic 
method for those who were exposed to arsenic during development.       
Taken together, this study provides a mechanistic approach on how arsenic affects 
stem cells differentiation. However, there are still questions needed to be elucidated. For 
example, we need to understand how the altered miRNAs regulate the downstream 
signaling (ie, what are the target genes) and how does this link back to arsenic and 
reduced stem cell differentiation?  Future studies should also investigate whether the 
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altered mechanisms seen in our stem cell culture system mimics that which is seen in vivo 
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